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Atopic disorders 
Asthma, allergy, hay fever and eczema are collectively known as “atopic 
disorders”, diseases which are associated with dysfunction of the immune 
system. In the western world the prevalence of these disorders in children has 
increased dramatically over the last decades of the past century. However, it is 
difficult to present exact figures, as estimates of prevalences and increases differ 
considerably between studies, but figures from repeated cross-sectional surveys 
indicate about a two- to threefold increase upto 30% over the past 20 years (1-
4). During the last decade this increase seems to level off (5). The fact that the 
increasing prevalence in the western world parallelled increasing prosperity and 
development and the fact that prevalences in the western world are about a 
tenfold of those in the non-western world (6), strongly suggest that aspects of 
modernisation are related to this increase. Support for this hypothesis came from 
research in West and East Germany (7, 8) which showed that five years after the 
unification (which rapidly changed living conditions) the prevalence of atopy in 
Eastern Germany had increased.  
 
The hygiene hypothesis 
Aspects of modern lifestyle are more hygienic living conditions and smaller 
families. Golding and Peters in 1986 were the first to describe the protective 
effect of family size or sibship size (the so-called “sibling effect”) for eczema and 
hay fever (9). This motivated David Strachan in 1989 to put forward a 
hypothesis, stating that more hygienic living conditions, and consequently less 
exposure to pathogens at a young age, would increase the risk of atopy (10). 
This idea was prompted by the finding that adults coming from large families had 
less hay fever than those from small families. This finding, and also the finding 
that individuals with more older siblings have less atopy, has been confirmed by 
many studies since (11). The link between this finding and the hygiene 
hypothesis is, that children with many siblings are more exposed to pathogens at 
a young age.  
Biological mechanism 
The hygiene hypothesis was first explained by the paradigm of an equilibrium 
between Th1- and Th2-lymphocytes. The immune system of a newborn baby is 
Th2-skewed because during pregancy the immune system of the mother shifts 
towards the Th2 side. Without this shift, no pregnancy would be successful, as 
Th1-lymphocytes are harmful to the fetus. After birth the balance between Th1-
and Th2-lymphocytes shifts towards the Th1 side as a result of exposure to 
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pathogens. If there is too little exposure, this shift would allegedly not take place 
completely and a Th2 environment, which promotes allergic inflammation, would 
be the result. However, several observations contradicted this paradigm, as for 
instance the prevalence of autoimmune diseases (which are Th1 related) has also 
increased. New research has led to the formulation of an interpretation in which 
early exposure to pathogens and allergens promotes the development of IL-10 
producing T-regulatory cells, which downregulate both the Th1 and the Th2-
lymphocytes (12, 13). 
Evidence 
A substantial amount of research has been carried out to test the hygiene 
hypothesis. As exposure to pathogens is difficult to measure, many studies 
investigated the relationship between infections and subsequent atopy. This may 
be the reason for the inconsistent evidence resulting from these studies. 
Considering infections as a proxy for exposure to pathogens harbours the 
possibility of reverse causation, for children predisposed to atopy have a different 
anti-viral immunity (14). Studies on the association between infections with 
orofecal pathogens (hepatitis A, Toxoplasma gondii) and parasites (helminths) 
showed an inverse relationship (15-17), which clearly support the hypothesis. 
Day care attendance at a young age is obviously associated with more 
exposure to pathogens and, in terms of exposure to other children, more or less 
comparable with a large family size. A German study (18) found a (positive) 
dose-response relationship between age at entry and the risk of atopy in small 
families, but this relationship was absent in children from large families. Some 
cross-sectional Scandinavian studies, however, did not confirm this finding, which 
might be due to differences in study design, but could also be due to residual 
confounding. 
 Growing up on a traditional farm, especially one with cattle, was 
associated with a much smaller risk of atopy according to studies carried out in 
the Alps (19, 20). Early contact with bacterial components (such as endotoxines), 
which is common on farms, has been suggested to be protective for the 
development of atopy, although a “healthy worker effect” cannot be rules out.  
 Pet keeping at a young age has been shown to be protective for atopy at a 
later age (21), but confounding by (contra-)indication can never be excluded in 
these studies. 
In summary, although the evidence is mostly based on observational studies 
and several forms of bias cannot be excluded, there is some evidence in favour of 
the hygiene hypothesis.  
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Vaccinations 
The National Vaccination Programme in the Netherlands was started in 1957, 
when it was realized that vaccination of infants and young children against 
serious infectious diseases is among the most cost-effective intervention in 
preventive health care. The programme has been extended gradually over time. 
Currently it comprises vaccinations for diphtheria tetanus pertussis poliomyelitis 
(DTPPo), Haemophilus influenzae type b (Hib), measles, mumps, rubella (MMR) 
and meningococcal c (Neis Vax). However, potential adverse effects of these 
childhood vaccinations have often been the subject of heated debate, both in the 
lay press and in the scientific literature. Several organisations of opponents of 
vaccinations, notably in the UK and the Netherlands, have diffused biased 
interpretations of scientific results, thus stimulating an ongoing trend, where 
longing for a natural lifestyle became more important than preventing serious 
infectious diseases. Ignoring the fear of adverse effects by public authorities 
could lead to a dangerously decreasing vaccination rate. 
 A potential relationship between vaccinations and atopy could be thinkable 
in two ways in the context of the hygiene hypothesis: on the one hand 
vaccinations prevent infections, and thus contribute to the “hygiene effect”; on 
the other hand vaccinated children are at a very young age exposed to 
(attenuated) pathogens or components of pathogens, a favourable situation 
according to the hygiene hypothesis. Also the exposure to vaccine additives, such 
as aluminium containing adjuvants, might change the risk of subsequent atopy. 
It is impossible to validly predict the relationship on theoretical grounds.  
Evidence 
We aim at investigating the longterm relationship between vaccinations and 
atopy. Short term reactions have been extensively studied and are less 
controversial.  
 A randomized controlled trial with an unvaccinated control group is not 
feasible for ethical reasons. Therefore almost all available studies are 
observational, implying that groups were compared without being randomized. 
Therefore it is likely that vaccinated and unvaccinated groups differed in more 
aspects than vaccination alone. This may be an explanation for diverging study 
results.  
 For the MMR vaccination the available studies show no difference, or even 
a lower risk of atopy in vaccinated children (22-24). So regarding MMR we can 
conclude that there is no evidence for a higher risk of atopy in vaccinated 
children (25).  
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 The Meningococcal group C vaccination has been introduced in the 
Netherlands in 2003. For this vaccination no evidence regarding the longterm 
relationship with atopy is available.  
 The relationship between the DTP(Po) vaccination, or the pertussis 
component alone, and atopy has been addressed in many studies (25-33), but 
the conclusions are inconsistent. Some studies found a higher risk of atopy in 
DTP vaccinated children (26-30), while other studies reported no difference or 
even a lower risk of atopy (22-24, 31-32). It is difficult to draw conclusions from 
the available evidence, because all studies are possibly subject to confounding by 
indication, as the reason for not vaccinating may be health related. Only one 
study was a randomized controlled trial (32). In this trial the additional effect of 
the pertussis component (in various forms) to the diptheria tetanus vaccinations 
was studied. No effect was found, but it was not possible to compare with an 
unvaccinated group. 
 For the Hib vaccination the available studies show no effect (23, 33) or a 
slightly higher risk of atopy for vaccinated children (24, 34), but the conclusion of 
these latter studies is that this weak relationship may be due to residual 
confounding.  
  
Birth order and sibship size 
The proportion of atopy cases attributable to the sibling effect has been 
estimated to be approximately 30% (35). But what is the underlying mechanism? 
Is it because children with many siblings are more exposed to “dirt” than children 
with no siblings or is it something else? Identification of the underlying 
mechanism is important for the design of a possible prevention strategy. 
However, different definitions of the sibling effect have been used, relating atopy 
to the number of older siblings, birth order, family size, the number of younger 
siblings and sibship size. In order to detect the underlying mechanism, we first 
need to know which definition of the sibling effect is the “real” risk factor. Several 
definitions are (almost) equivalent: the number of older siblings and birth order 
are equivalent, because birth order equals the number of older siblings plus one; 
sibship size parallels family size; and sibship size minus the number of younger 
siblings equals the number of older siblings plus one. Therefore it would be 
sufficient to disentangle the roles of birth order and sibship size as risk factors for 
atopic disease. The underlying mechanism could be either prenatal or postnatal 
or both. 
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Perinatal risk factors 
It has been suggested that some important risk factors for atopy already operate 
during pregnancy and many studies have focussed on the relationship between 
perinatal data and atopy. The effect of prematurity on subsequent lung function 
and the positive relationship with wheezing is well known (36). On the other 
hand, there are also reports of high gestational age being a risk factor for atopic 
disease in adults (37). However, conclusions are not unequivocal, because many 
other studies did not find such relationships. Also head circumference at birth and 
subsequent atopy has been the subject of a number of studies. A positive 
association between neonatal head circumference and total IgE concentration 
was first reported in 1994 (38) and confirmed by others (39-41). This finding 
raised the hypothesis that this positive association might reflect the long-term 
effect of sustaining fetal brain growth at the expense of the trunk, in particular 
the thymus (38). More recently, this hypothesis was challenged by the finding 
that thymus size is not related to allergic disease (42) and that the relationship 
between the ratio of head circumference to birth weight and hay fever is negative 
(43).  
 Complications and interventions during labour, for instance caesarean 
section, were also found in some studies to be related to asthma in later life (42, 
44). Understanding the mechanisms underlying these relationships could possibly 
contribute to the prevention of these disorders.  
 
Objectives of the studies 
The following objectives were formulated in order to address the questions 
introduced above: 
1. To assess the relationship between the DTPPo vaccination and reported atopic 
disease at age 8-12. 
2. To assess the relationship between the Hib vaccination and reported atopic 
disease at age 8-12. 
3. To disentangle the effects of birth order and sibship size on reported atopic 
disease at the age of six years. 
4. To assess the relationships of various perinatal characteristics and obstetric 
complications with reported atopic disease at age six. 
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The studies 
Study population I 
In the Netherlands, the Orthodox Reformed religion is a subdivision of the 
Protestant Church. About 6% of the Dutch population adheres to this religion 
(45). Children from this religious group attend Orthodox Reformed schools which 
are clustered in an area which stretches from the South-West of the Netherlands 
to the East. Many of these people refuse vaccinations for religious reasons. This 
group is very suitable to answer our first two questions, because within one, 
rather homogeneous, population there are exposed and unexposed individuals. 
Moreover, the reason for refusing vaccinations is essentially religious, and not, as 
in other studies on this subject, possibly health related.  
 Our method was to distribute questionnaires in classes 5-8, corresponding 
to age 8-12, of Orthodox Reformed primary schools. These questionnaires 
included, apart from a Dutch translation of the ISAAC-questionnaire (46) on 
symptoms of atopic disorders, questions on childhood vaccinations and other 
known risk factors for atopy. Altogether 4480 questionnaires were distributed and 
1875 (42%) were returned. In a subgroup of 100 children blood samples were 
taken with two purposes: 1) to determine specific IgE for house dust mite, cat, 
dog, grass pollen and birch pollen to get an objective measurement of atopy and 
2) to determine levels of tetanus and diphteria antibodies in order to get a 
validation of the reported vaccination status. As an additional validation we 
compared the vaccination status reported in the questionnaire with that officially 
registered in National Vaccination Registries in another subgroup of 120 children.  
Study population II 
To address the third question (birth order and sibship size) we selected a 
retrospective cohort of 700 families in the municipality of Zwijndrecht with index 
children born in 1988-1990 and, from files of the District Health Service of 
Zwijndrecht, extracted data concerning atopic disease at the age of six years and 
other relevant variables of all the index children and their brothers and sisters. 
Children in the Netherlands get a routine health check-up at the age of six and 
data concerning atopic disease were reported by a parent during these check-ups 
and recorded by the examining physician. The files also contain data collected at 
other points in time, like perinatal data and vaccination data. The perinatal data 
comprised data on special interventions before or during labour (such as 
caesarean section, vacuum or forceps extraction, induced labour), gestational 
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 A part of these children was not vaccinated for religious reasons and we 
were therefore able to address the first question as well. However, the number of 
unvaccinated children was small (n=44), and we were not able to differentiate 
between the pertussis component alone, the cocktail of DTPPo, or the mumps 
measles rubella (MMR) vaccination. 
 The data, routinely collected during health check-ups from birth onward, 
enabled us to also address the fourth question regarding the relationship 
between perinatal characteristics and atopic disorders at age six. 
 
Outline of the thesis 
Chapter 1: gives an introduction and discusses the background of the thesis. 
Chapter 2: addresses the question on the relationship between the DTTPo 
vaccination and reported atopic disease at age 8-12 years (study population I, 
objective 1).  
Chapter 3: addresses the relationship between the pertussis component of the 
DTPPo vaccination and reported atopic disease at age six in study population II 
(objective 1). 
Chapter 4: addresses the question on the relationship between the Hib 
vaccination and reported atopic disease at age 8-12 years (study population I, 
objective 2). 
Chapter 5: addresses the question on disentangling the relationships of birth 
order and sibship size with reported atopic disease at age six (study population 
II, objective 3). 
Chapter 6: addresses the question on the relationship between perinatal 
characteristics and reported atopic disease at age six (study population II, 
objective 4). 
Chapter 7: gives a discussion of the results of this study, recommendations for 
future research and for communication of study results and possible prevention 
strategies.  
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Abstract 
Background: Evidence for the relationship between the diphtheria tetanus 
pertussis (DTP) vaccination and atopic disorders is inconclusive, because the 
available studies that constitute the evidence are liable to confounding by 
indication. 
Study objective: To assess the relationship between diphtheria-tetanus-
pertussis-poliomyelitis (DTPPo) vaccination in the first year of life and reported 
atopic disorders at primary school age. 
Method: 1875 children attending Orthodox Reformed (Protestant) primary 
schools in the Netherlands returned questionnaires with data on vaccination 
status, atopic symptoms and lifetime atopic disorders (asthma, hay fever, 
eczema and food allergy), and possible confounders.  
Results: The adjusted odds ratio of any atopic disorder 
(vaccinated/unvaccinated) was 1.00 (CI95%: 0.80 - 1.24). For asthma, hay fever, 
eczema and food allergy the results were respectively: 1.04 (CI95%: 0.76 - 1.42), 
0.79 (CI95%: 0.55 - 1.12), 0.87 (CI95%: 0.66 - 1.14) and 1.13 (CI95%: 0.71 - 
1.81). 
Conclusion: The DTPPo vaccination was not related to reported atopic disorders 
at primary school age.  
Key words: DTP vaccination, atopy, asthma 
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Introduction 
The prevalence of allergic disorders has increased during the past decades and 
much effort has been put into identifying risk factors for these disorders. These 
include elements of western lifestyle such as increased hygiene and subsequent 
decreased exposure to pathogens and number of infectious diseases. The 
potential influence of childhood vaccinations is often the subject of heated 
debate, both in the lay press and in the scientific literature. Organisations of 
opponents of vaccinations  (especially in the UK and the Netherlands) have 
spread biased interpretations of scientific results, thus stimulating an ongoing 
trend whereby the longing for a natural lifestyle takes precedence over the fear 
of serious infectious diseases. 
Many studies have investigated the relationship between childhood 
vaccinations and allergic disorders. A recent systematic review concluded that 
these vaccinations do not cause allergic diseases (1). However, concerning the 
diphtheria tetanus pertussis (DTP) vaccination, this conclusion is controversial 
(2), mainly because of the possibility of bias in these studies. For in all these 
(observational) studies the reason for not vaccinating may well have been health-
related and thus outcome-related, which is a classic example of confounding by 
indication. A randomised controlled trial would avoid this bias, but may not be 
feasible for ethical reasons.  
In the Netherlands about 6% of the population adhere to the Orthodox 
Reformed (Protestant) religion and many in this group refrain from vaccinations 
for religious reasons. We conducted an observational cross-sectional study within 
this religious group to study the relationship between the DTP-Poliomyelitis 
(DTPPo) vaccination and atopic disorders, at the same time minimizing the 
problem of confounding by indication.  
Aim of the study 
To assess the relationship between receiving the DTPPo vaccination in the first 
year of life and reported atopic disorders at primary school age. 
 
Methods 
Childhood vaccinations in the Netherlands 
According to the National Vaccination Programme, infants get four vaccinations of 
DTPPo and Haemophilus influenzae type B (HiB) in their first year of life. At 14 
months children are immunized with the measles mumps rubella vaccine (MMR) 
and meningococcal c vaccine (Neis Vax). At four years children receive a 
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vaccination for diphtheria tetanus poliomyelitis (DTPo) and acellular pertussis 
(aP), and at nine years DTPo and MMR. Because the Hib vaccination was 
introduced in 1993 and the Neis Vax in 2003, part of the population under study 
did not regularly receive the HiB vaccination and the whole population received 
the Neis Vax (if accepted) at age 7 years or older. 
Study area, population and design 
In the Netherlands the Orthodox Reformed religion is a subdivision of the 
Protestant Church. Children from this religious group attend Orthodox Reformed 
schools which are clustered in an area which streches from the south-west of the 
Netherlands to the east.  Many of these people refuse vaccinations for religious 
reasons. 
In a cross-sectional design we assessed by means of questionnaires the 
relationship between receipt of the DTPPo vaccination in the first year of life and 
atopic symptoms or lifetime disease at age 8-12 years.  
Permission was requested from the Boards of the Orthodox Reformed 
primary schools to distribute letters of invitation, information and questionnaires 
directed to the parents of children aged 8-12 years. In most cases these letters 
were also signed by a staff member of the coordinating District Health Service in 
the region at issue.  
 The study was approved by the Ethics Committee of  Erasmus MC and all 
participants (parents) gave informed consent for participation in the study.  
 The study was financed by the Department of General Practice of Erasmus 
MC. AstraZeneca, who provided the anaesthetic patches, had no role in the 
design, collection, analysis and interpretation of the data, writing of the report or 
the decision to submit the paper for publication. 
Sample size calculation 
We assumed a significance level of 5%, a power of 80%, and a prevalence of 
allergic disorders of 10% in the lowest risk group. Our aim was to detect an 
absolute risk difference of at least 5%. It was unknown beforehand what the 
distribution of the risk factor under study would be in our population. However, 
we assumed a distribution that would not be skewed more than 3:7, i.e. 30% 
vaccinated children and 70% unvaccinated children (or vice versa). In the 
statistically most unfavourable situation, 10% atopic disorders in the smallest 
group (30%) and 15% atopic disorders in the other group (70%), we would need 
a total of 1769 children to detect this difference (corresponding to an odds ratio 
of 1.6) with a two-sided test.  
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Participating schools and children 
Relevant schools were approached by mail (and subsequently by telephone) 
requesting permission to distribute packages containing a letter of invitation, 
information about the study, informed consent form and a questionnaire. We 
continued approaching schools until we judged that the required number of 
questionnaires would be returned. Of the 55 schools that were asked for 
permission 17 (31%) refused, mainly because the Boards expected the topic of 
vaccinations to be too sensitive. In total 4480 packages were distributed in the 
period autumn 2003 - spring 2004 in classes 5-8 (corresponding to age 8-12 
years) of the 38 participating schools. In total 1875 questionnaires (42%) were 
returned of which 1872 were suitable for analysis. 
Data collection 
One of the parents, preferably the mother, was asked to fill out the 
questionnaire. Informed consent contained questions on consent to participate in 
the study, consent for the investigator to obtain officially registered vaccination 
data, blood sampling (for validation purposes in a subset of the participants), and 
storage of the data. The questionnaire asked for symptoms of (and physician 
diagnosis of) asthma, hay fever and eczema (Dutch translation of the ISAAC 
questionnaire (3, 4)), physician-diagnosed food allergy ever, childhood 
vaccinations, BCG vaccinations and influenza vaccinations, gender, passive 
smoking (prenatally, during the first year of life and currently), date of birth, 
perinatal data, birth order, ZIP code, year of birth of the mother, any atopic 
disorders of parents or siblings, family composition, education, income, living 
conditions (current and during the first year of life), day care attendance, breast 
feeding, nutrition during the past month, frequency of exercise, body length and 
weight, and having had common infectious diseases preventable by vaccinations 
(measles, mumps, rubella and pertussis). 
Statistical analysis  
The relationship between the DTPPo vaccination in the first year of life and 
(current symptoms or “ever had”) asthma, hay fever, eczema, food allergy, and 
“any atopic disorder” (at least one of these diseases) was evaluated by means of 
logistic regression. In the main analyses we ignored the questions on physician 
diagnosis because the more conservative religious adherents are possibly less 
inclined to visit their general practitioner thus introducing bias. However, we 
repeated all analyses with physician-diagnosed disorders as outcomes. Analyses 
were performed both in univariate and multivariate models. Potential confounders  
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are shown in Table 1. A variable  was included in the multivariate model if it 
changed the univariate point estimate by at least 10% (5).  
  The question on income is often a sensitive one which people tend to skip. 
Therefore, for those participants who did not answer this question we ranked 
them according to income data linked to their ZIP code (6) and imputed a code 
for income such that the total distribution of income remained the same as it was 
for the participants who did answer this question.  
The main analyses were repeated taking the multilevel structure (level 1: 
children/level 2: families/level 3: schools) into account.  
For the imputation procedure (see “Objective measurement of allergy”) 
we used a multiple imputation technique with five imputed data sets (7). 
Analyses were carried out on each of these five sets and results were pooled (7). 
Imputation was done with IVEware version 2.0. 
 SPSS version 11.0 and ML-win version 1.1 were used for all other 
computations. A two-sided p-value of 0.05 or less was considered significant in 
all tests.    
Objective measurement of allergy 
In total 72% of the participants gave informed consent for a blood sample 
(73.6% of the vaccinated, and 70.3% of the unvaccinated children). From these 
children we selected a random stratified sample of 100 children. Stratification 
was performed such that there was a 1:4 distribution of DTPPo vaccination 
(yes/no) and an equal distribution of atopic symptoms (yes/no) and primary 
school class (5/6/7/8). Two research assistants visited the participating schools 
to take the blood samples. Emla® anaesthetic patches (AstraZeneca, 
Zoetermeer, The Netherlands) were used to minimize needle pain. We performed 
RAST tests using the Pharmacia® RIA method to determine specific IgE to five of 
the most common aero allergens in the Netherlands (house dust mite (d1), 
cocksfoot pollen (g3), common silver birch pollen (t3), cat epithelium and dander 
(e1) and dog dander (e5)) in the sera of these 100 children to obtain an 
objective measurement of allergy.  
Allergy was defined as at least one RAST class 2 or higher (i.e. IgE >=0.7 
IU/ml); we linked this objective variable to reported asthma or hay fever (current 
symptoms or “ever had”). Moreover, on the basis of these objective allergy data 
of 100 children and other relevant variables, we imputed the objective allergy for 
the remaining 1773 children.  
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Table 1  Potential confounders in the relationship between the DTPPo vaccination 
and atopic disorders 
 
Season of birth 
Birth order 
Gender 
Gestational age 
Birth weight 
Age of  the mother at the time of delivery 
Exposure to smoking (prenatally, during the first year of life and currently) 
Breast feeding for four months or more (yes/no) 
Housing in the first year of life (rural and living on a farm with livestock/ 
rural other / city) 
Pet keeping (furry pets or birds yes/no) during the first year of life and 
currently 
Day care starting at age 6 months or less (yes/no) 
Current age 
Asthma and/or allergy of the parents and/or siblings 
Highest educational level of the parents 
Family income 
Current level of urbanization (five levels) 
Living on a farm with livestock (yes/no) 
Sibship size 
Mould in the child’s bedroom in the past year 
Frequent (more than five days/week) consumption of  
fruit (yes/no) 
(raw or cooked) vegetables (yes/no) 
anti-oxidants (yes/no) 
unskimmed dairy products (yes/no) 
wholemeal bread (yes/no) 
Frequent (at least one day/week) consumption of fish 
Frequent  exercise (school gym at least once a week and playing games with 
physical activity for at least half an hour a day and either being a  
member of a sporting club or walking or cycling from home to school  
vice versa for at least one hour a day) 
Body mass index 
HiB vaccination
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Validation of the risk factor 
To validate our question on the DTPPo vaccination we performed tests for tetanus 
toxoid IgG and diphtheria IgG antibodies in the sera of the 80 children (from the 
sample of 100 mentioned under “Validation of the outcome”) that according to 
their parents were DTPPo unvaccinated. All sera were stored at minus 20 degree 
celcius until being tested in one run. The following EIA kits were used to test for 
tetanus toxoid IgG and diphtheria IgG antibodies: RIDASCREEN® Tetanus test 
and RIDASCREEN® Diphtheria test (both R-Biopharm, Germany). Children with 
titres of at least 0.6 IU/ml were considered as being vaccinated for the pathogen 
concerned. 
In addition we randomly selected a group of 120 children [of those 1761 
(94.1%, 99.0% of the vaccinated and 85.2% of the unvaccinated children) who 
gave informed consent to obtain officially registered vaccination data] and 
compared the official registrations of the vaccinations in the first year of life with 
those reported by the parents. 
Assessment of selection bias 
In case of a low response rate the possibility of selection bias had to be 
evaluated. If selection bias would be present, at least one of the four cells (no 
atopy/noDTPPo, atopy/noDTPPo, no atopy/DTPPo, atopy/DTPPo) would be over- 
or underrepresented, thus causing a spurious relationship. Selection bias is 
unlikely if no selection on DTPPo vaccination has occurred. In order to verify this 
we asked the District Health Services covering the participating schools to 
estimate from their records the vaccination coverage per school. Thereafter, we 
compared the vaccination coverage of the responders for each school separately, 
and the total in all schools, with the vaccination coverage reported by the District 
Health Services.  
Finally, we assessed the odds ratios (ORs) pertaining to the relationship 
under study and the response rate for each school separately and checked by 
means of linear regression, weighted with the inverse of the squared standard 
error of the log(OR), whether there was a relationship between the log(OR) and 
the response rate. In case of selection bias one would expect a (negative or 
positive) relationship between ORs and response rate. 
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Results 
Relationship between DTPPo and atopy 
A total of 1875 children returned the questionnaire (a response rate of 42%), of 
which three questionnaires were excluded because of missing vaccination status. 
Of the remaining 1872 children, 671 (35.8%) were not vaccinated for DTPPo in 
the first year of life. Of the 1201 vaccinated children, 21 (1.7%) were 
incompletely vaccinated for DTPPo (i.e. they did not receive all four vaccinations 
scheduled in the first year of life).  
Of all children, 873 (46.6%)  reported any form of lifetime atopic disorder. 
Characteristics of the children, by DTPPo vaccination status, are presented in 
Table 2.  
 Table 3 shows prevalences and both univariate and multivariate ORs with 
95% confidence intervals (CI95%) for the relationships between DTPPo 
vaccinations and atopic disorders. Atopy appeared to be slightly more prevalent 
in vaccinated children [univariate OR=1.27, CI95%=(1.05-1.59)], but this 
difference disappeared when we adjusted for confounders [OR=1.00, 
CI95%=(0.80-1.24)]. The differences for the separate disorders were small and 
not significant (Table 3). In all models family size, education and atopic history of 
parents or siblings proved to be confounders. When we analysed the models with 
physician-diagnosed diseases as outcome variables the adjusted ORs tended to 
be somewhat larger, although they were never statistically significant: for any 
atopic disorder the adjusted OR was 1.04 [CI95%=(0.82-1.31)] (Table 4). 
Multilevel analysis of the multivariate models presented in Table 2 yielded 
similar results (data not shown). 
Objective measurement of allergy 
Of the 100 children who donated blood, 46 (46.0%) reported symptoms of (or 
ever had) asthma or hay fever. Of these, 26 (56.5%) were allergic according to 
the RAST results. Of the remaining 54, who reported neither asthma nor hay 
fever, 40 (74.1%) were not allergic according to the RAST results. Of the 
remaining 14 (who had at least one RAST class 2 or higher and did not report 
asthma or hay fever), 7 (50%) reported symptoms of eczema. Table 5 shows 
these data, also broken down by vaccination status. It seems that, although the 
numbers are small, vaccinated children who reported asthma or hay fever, have 
less allergy according to our objective measurements than unvaccinated children 
(27% and 66%, respectively).  
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Table 2 Characteristics of the participating children by DTPPo vaccination status 
  Unvaccinated  
N=671 *          %    
Vaccinated  
N=1201 *  % 
Gender Male 
Female 
 
52.5 
47.5 
50.3 
49.7 
Age (years) < 10 
>= 10 
Unknown 
 
44.0 
55.7 
0.3 
42.2 
57.4 
0.4 
Atopic disorders in 
parents  
and/or siblings 
Yes 
No 
Unknown 
 
61.3 
38.6 
0.1 
65.5 
34.0 
0.5 
Highest education of 
parents 
Primary or less 
Lower professional & lower secondary 
Medium professional 
Higher secondary 
High professional &  university 
Unknown 
 
0.4 
34.1 
28.5 
10.1 
26.5 
0.3 
0.4 
23.8 
29.2 
15.0 
31.1 
0.4 
Number of children 
in the family 
1 
2 
3 
4 
5+ 
Unknown 
 
0.7 
1.8 
9.2 
22.5 
65.6 
0.1 
1.2 
15.2 
30.1 
22.6 
30.8 
0.2 
Pertussis infection** 
Mumps infection** 
Measles infection** 
Rubella infection** 
Yes 
Yes 
Yes 
Yes 
 
42.2 
7.3 
86.1 
22.2 
 
8.9 
2.9 
18.4 
6.5 
HiB vaccination 1st year 
 
Yes 
No 
Unknown 
0.0 
99.6 
0.4 
54.3 
34.8 
10.9 
Pertussis part of DTPPo 
1st year 
(vaccinated only) 
Yes 
No 
Unknown 
 90.1 
3.8 
6.1 
MMR at 14 months Yes 
No 
Unknown 
0.1 
99.6 
0.3 
89.7 
8.4 
1.9 
* Unvaccinated means: no DTPPo vaccination in the first year of life; vaccinated means: at least one 
DTPPo vaccination in the first year of life. For 3 children this characteristic was unknown. 
** Reported infection
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Table 3 Atopic disorders for (diphtheria tetanus pertussis poliomyelitis) 
vaccinated and unvaccinated children: prevalences (%) and crude and adjusted 
(adj) odds ratios (OR) with 95% confidence intervals (CI95%) 
  % OR Adj OR CI95% 
Asthma* Vaccinated
Unvaccinated
15.2
12.4
1.28 1.04
 
0.76-1.42 
 
Hay fever* Vaccinated
Unvaccinated
17.9
16.2
1.14 0.79
 
0.55-1.12 
 
Eczema* Vaccinated
Unvaccinated
34.2
31.1
1.14 0.87
 
0.66-1.14 
 
Food allergy* Vaccinated
Unvaccinated
7.9
6.3
1.29 1.13
 
0.71-1.81 
 
Any atopic disorder* Vaccinated
Unvaccinated
48.7
42.9
1.27 1.00
 
0.80-1.24 
 
 
*Ever had the disease or having symptoms at present 
 
 
 
 
 
 
Table 4 Physician diagnosed atopic disorders for (diphtheria tetanus pertussis 
poliomyelitis) vaccinated and unvaccinated children: prevalences (%) and crude 
and adjusted (adj) odds ratios (OR) with 95% confidence intervals (CI95%) 
  % OR Adj OR CI95% 
Asthma Vaccinated
Unvaccinated
11.4
9.5
1.23 1.03
 
0.72-1.46 
Hay fever Vaccinated
Unvaccinated
5.5
4.3
1.30 1.06
 
0.59-1.90 
Eczema Vaccinated
Unvaccinated
22.6
19.7
1.19 0.96
 
0.73-1.25 
Food allergy Vaccinated
Unvaccinated
7.9
6.3
1.29 1.13
 
0.71-1.81 
Any atopic disorder Vaccinated
Unvaccinated
33.2
28.3
1.27 1.04 0.82-1.31 
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Table 5 Reported asthma and/or hay fever versus objective allergy in a subset of 
participants (n=100) 
 
 
 
  Objective allergy** Total 
Reported 
symptoms* 
 No yes  
DTPPo  no 33
73%
12
27%
45 
100% 
yes 7
78%
2
22%
9 
100% 
No 
Total 40
74%
14
26%
54 
100% 
DTPPo  no 
 
12
34%
23
66%
35 
100% 
yes 8
73%
3
27%
11 
100% 
Yes 
Total 20
44%
26
56%
46 
100% 
 
*Symptoms or ever had asthma and/or hay fever 
** at least one RAST class 2 or higher (i.e. IgE  ≥ 0.7 IU/ml) (out of five RASTs 
for: house dust mite, grass pollen, birch pollen, cat dander and dog dander) 
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Analysis of the imputed datasets yielded an adjusted OR for objective  
allergy (DTPPo+/DTPPo-) of 0.38 [CI95%: (0.18-0.82)], suggesting a protective 
effect of vaccinations.  
Validation of the risk factor 
Of the 80 allegedly DTPPo unvaccinated (in the first year of life) children tested 
for tetanus toxoid IgG and diphtheria IgG antibodies, six proved to have titres of 
tetanus toxoid IgG of at least 0.6 IU/ml. However, four of these indicated in the 
questionnaire that they had a tetanus vaccination after an accident. Two of the 
remaining children also had titres of diphtheria IgG of at least 0.6 IU/ml. A third 
child had a diphtheria IgG titre over 0.6 IU/ml, but its tetanus titre was only 0.32 
IU/ml. These results raise doubt about the vaccination status of three out of 80 
allegedly unvaccinated children (3.8%). 
 We requested official vaccination registration data for 120 children, of 
whom 3 turned out to be untraceable. Comparison of reported infant vaccinations 
with the official registration data in the remaining 117 participants yielded a 
perfect match in 107 children (91.5%): in four cases there was disagreement 
about the pertussis component and in five cases about the HiB vaccination. On 
the DTPPo vaccination there was disagreement in only one case. 
Selection bias 
For each school we compared the vaccination coverage according to the records 
of the District Health Service with the vaccination coverage in our responders. 
Results for all 38 schools are shown in Figure 1. The mean difference is 0.1% (sd 
6.4%). The vaccination coverage for all schools, estimated with the help of the 
records of the District Health Service, was 63.8%, whereas the vaccination 
coverage of the responders was 63.1%.  
 Figure 2 shows for 37 schools (for one school which had 100% vaccination 
coverage, no OR was computed) the relationship between the ln(OR) of atopy 
(DTPPo+/DTPPo-) and the response rate. The weighted linear regression line 
seems to be descending slightly, indicating a possible small decrease of the OR 
with increasing response rate. 
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Figure 1  Vaccination coverage in the 38 schools 
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Figure 2 Relationship between the logarithm of the odds ratio (any 
atopy) (DTPPo+/DTPPo-) and response rate to the questionnaire 
in 37 schools* 
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Values > 0 on the y-axis correspond to a higher risk of atopy for 
vaccinated children   
         Linear regression line: beta = -1.06 CI95% = (-3.15,1.04) 
* In one school no odds ratio could be estimated because all children 
were vaccinated 
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Discussion 
The present study showed no relationship between the DTPPo vaccination in the 
first year of life and reported atopic disorders in primary school children. This is 
the first study to compare vaccinated and unvaccinated children in a population 
where refraining from vaccinations is unlikely to be health related. Moreover, the  
two groups had the same religious background, lived in the same area and 
attended the same schools. Possible differences were extensively surveyed and 
controlled for in the analyses. This situation is second best after a randomized 
controlled trial, which would not be feasible for ethical reasons.  
 Koppen et al. concluded in their review (1), that the DTP vaccination does 
not cause allergic disease. This conclusion was not entirely justified, because 
confounding by indication could have caused biased results in all studies included 
in their review and, moreover, the conclusions of these studies were not 
unequivocal (2). However, the results of the present study support the conclusion 
that the DTPPo vaccination indeed is not associated with allergic disease. 
 Atopic disorders of family members could be viewed as intermediate 
variables in the relationship between vaccinations and atopy, because the 
vaccination status of family members is likely to be highly correlated. However, 
we considered this predictor to be too important to omit from the models.  
Vaccinations other than the DTPPo were not included in the model, 
because having had other vaccinations was highly correlated to acceptation of the 
DTPPo vaccination. An exception was the HiB vaccination; this was introduced in 
1993 and, consequently, a major part of the otherwise vaccinated children did 
not get the HiB vaccination.  
Another consequence of the fact that almost all DTPPo unvaccinated 
children were completely unvaccinated is that our conclusion, that the two groups 
do not differ in prevalence of atopic disorders, applies to childhood vaccinations 
in general. In this respect also concerns about additives (such as the aluminium-
containing adjuvans), are not supported by the present study. 
We did not include histories of infections of pertussis, mumps, measles 
and rubella in the multivariate model, as these are obviously intermediate 
variables in the relationship between vaccinations and atopy. Moreover, also 
reversed causation could play a role because children predisposed to allergic 
disease have a different antiviral immunity (8). Finally, it is plausible that these 
diseases were more often diagnosed in the unvaccinated group, also because 
they probably result in more symptoms. Children with a reported history of 
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pertussis, mumps and measles reported more atopy, but for children who 
allegedly had had rubella less atopy was reported.  
Physician-diagnosed atopy showed similar results as self-reported atopy, 
but indicating slightly more atopy in the vaccinated group. This difference may be 
explained by the possibility that unvaccinated (probably more traditional) people 
tend to be less inclined to visit their general practitioner. Possible health care 
utilization bias was the reason why we took reported symptoms and disease as 
the main outcome variable. 
In a previous study (not included in the review mentioned above) we 
concluded that pertussis vaccinated children had a lower risk of atopic disorders 
(9). However, this conclusion was based on only 44 possibly genetically related, 
unvaccinated children who attended the same school. Also, our analysis of 
objective allergy with imputed data showed an almost identical result, but these 
estimates were based on a subsample of 100 children (with only 20 vaccinated 
children) and should therefore be viewed with caution. Maybe parents’ reports of 
their child’s symptoms are influenced by the knowledge that they are participants 
in a study, whereas objective measurements are not. 
Limitations of the study 
Design: The design was cross-sectional, implying that some variables were 
assessed retrospectively. This applies mainly to confounders concerning 
pregnancy and the first year of life, but not to vaccinations, as these were 
registered at the time they were administered. Parents receive a list with their 
child’s vaccinations. 
Reliability of the outcome: The outcomes analysed in the present study are 
symptoms of atopic disease reported by the parents. Total agreement with our 
objective definition of allergy was 66%: just over half of the children reporting 
symptoms showed allergic sensitization and about one quarter of the children 
without symptoms were sensitized. Similar figures are also found in the literature 
(10). 
Reliability of the risk factor: In sera of a random stratified sample of 80 
children who were not DTPPo vaccinated in the first year, we checked whether 
tetanus toxoid IgG or diphtheria IgG antibodies above a relevant level could be 
detected. Moreover, in a random sample of 100 children, we compared the 
reported DTPPo vaccination with the officially registered vaccination data. Based 
on the results of these checks, we conclude that the main risk factor was fairly 
reliably reported, although some misclassification was detected. Moreover, only 
85% of the unvaccinated children (vs 99% of the vaccinated children) gave 
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informed consent to obtain official registration data; for blood samples this was 
73% and 75%, respectively. These figures could raise some concern about the 
reliability of the reported risk factor, because parents may have reasons to 
conceal the true vaccination status of their children. On the other hand, it would 
be more likely that these people would refuse to participate in the study at all.  
Response rate: Because only 42% of the approached children responded, the 
possibility of selection bias had to be evaluated. We checked this in two ways: 
first we compared the vaccination coverage of the responders with the 
vaccination coverage of the target group. The difference was less than 2%, 
implying that no selection on vaccination status had occurred; this made 
selection bias unlikely. Secondly, for the 38 participating schools we investigated 
the relationship between the response rate and the relationship between DTPPo 
and atopic disorder. There appeared to be a slightly negative trend, i.e. if there 
would be selection bias, the “true” OR would be smaller (i.e. a relatively smaller 
risk of atopy in vaccinated children) than the OR in our results.  
External validity: The study was conducted in a relatively homogeneous group 
of people, all from a common cultural background. Although this is a strong 
aspect of the study design, it could also raise questions about the generalizability 
of the conclusions. However, there is no reason to assume that the group of 
people under study differ biologically from the general Dutch population such that 
childhood vaccinations would have a different impact on atopy.  
 
Conclusion 
In the Dutch population the DTPPo vaccination is not associated with a higher risk 
of reported atopic disorders at primary school age.  
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Abstract 
Study question: Do whole cell pertussis-vaccinated children have a different risk 
of atopic disorders compared to children who did not receive this vaccination? 
Methods: Data on vaccination status, atopic disorders and child and family 
characteristics of  children of 700 families were collected in a retrospective study. 
A minority of these 700 families refused vaccinations for religious reasons. The 
relation between pertussis-vaccination status and atopic disorders was analysed 
by means of adjusted logistic regression for repeated measurements in order to 
account for the correlation between sibship members. 
Results:  The 700 families comprised 1961 children. Data on vaccination status 
and atopic disorders were available for 1724 children. Vaccinated children had a 
reduced risk of atopic disorders (adjusted OR: 0.37, CI95%: 0.16-0.87). 
Answer to the question: Whole cell pertussis vaccination is associated with a 
lower risk of atopic disorders, but we cannot exclude that other vaccine 
components (diphtheria, tetanus, poliomyelitis) or other vaccinations are also 
involved.  
Keywords: Whole cell pertussis vaccination, atopy, asthma, allergy, eczema  
 
Eur Respir J 2003;22:962-4. 
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Introduction 
An increased risk of atopic disorders in pertussis or diphtheria tetanus pertussis 
(DTP) vaccinated children has been reported (1, 2, 3, 4), but this was not 
confirmed by more recent observational studies (5, 6, 7), a randomized placebo-
controlled trial (8),  and an ecological study (9). Reports of adverse effects of 
vaccinations usually cause a lot of commotion and debate between advocates and 
opponents of vaccination programs. Within a study of family size and birth order 
as risk factors for asthma, allergy and eczema in a population of 700 families in 
the Netherlands we evaluated the role of the pertussis vaccination as risk factor 
for atopic disorders.  
 
Material and Methods 
Study subjects: In a study in the Netherlands designed to determine the role of 
sibship size and birth order as risk factors for asthma, allergy and eczema 700 
families with index children born in 1988, 1989 or 1990 were sampled from files 
administered by the Municipal Health Service covering the municipality of 
Zwijndrecht, a town with over 40,000 inhabitants. A subgroup of these families 
adhere to the orthodox reformed religion; their children mostly attend orthodox 
reformed schools. Some of the parents of this group refrain from vaccinations for 
religious reasons. According to the official schedule in the Netherlands children 
receive four vaccinations of DTP (whole cell)-Poliomyelitis and Haemophilus 
influenzae type B under the age of one year (before 1998 at the age of 3, 4, 5 
and 11 months), mumps-measles-rubella (MMR) at the age of 14 months, a 
booster of DT-Poliomyelitis at the age of 4 and 9 years and a booster of MMR at 
the age of 9 years. Since 2002 a booster of acellular pertussis is administered at 
the age of 4 years. 
Study design: Retrospective study using datafiles from routine health check-ups 
from birth till adolescence. 
Methods: Data on preventive health check-ups of index children performed by 
the Municipal Helath Service at the age of six years were collected from the files. 
Data from files of their siblings were also extracted. The following data were 
used: presence and type of allergy, asthma, eczema, current medication, birth 
order, sibship size, date of birth, gender, date of check-up, year of birth of the 
mother, postal code, country of birth of the parents, occupation of the bread-
winner, atopic disorders of the parents, vaccination status, and duration of 
breast-feeding. A child was considered having asthma, allergy or eczema, if this 
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was mentioned in the file by the physician who did the check-up, in the 
questionnaire filled out by the parents or in a letter from a 
paediatrician/pulmonologist.  
Analysis: The independent relation of pertussis-vaccination status with allergy, 
eczema, asthma and any atopic disorder (allergy, eczema or asthma) was 
evaluated within families by means of logistic regression for repeated 
measurements (Generalized Estimating Equations) (10), families being the units 
of analysis, which takes correlation between family members into account (SAS 
PROC GENMOD). Analyses were performed both in univariate and multivariate 
models with adjustments for the subset of the following variables which changed 
the univariate point estimate by at least 10% (11): sibship size, birth order, year 
of birth, season of birth, gender, breast feeding for more than one month 
(yes/no), age at the time of check-up, allergy or asthma of the parents, level of 
occupation of the bread-winner (five levels), age of  the mother at the time of 
delivery, level of urbanization (two levels) and country of origin (both parents 
born in the Netherlands yes/no). A two-sided p-value of 0.05 was considered 
significant.  
 
Results 
The 700 families comprised 1961 children. Both vaccination status and atopic 
status was available for 1724 children; of these 44 (2.6%) were not vaccinated 
for pertussis, mostly for religious reasons. Of these 39 had received no 
vaccinations at all, four received only the polio-vaccination, and one received DT-
polio (without pertussis). The 1724 children had their health check-up at a mean 
age of 5.9 years (sd: 0.6 years). The types of allergy mentioned were: house-
dust mite, pollen, furry pets, food allergy, hay fever and allergic rhinitis. The 
prevalence of atopic disorders in both groups is shown in the table. Crude odds 
ratios for atopic disorders (vaccinated/unvaccinated) varied between 0.33 and 
0.69. Adjusted odds  ratios ranged from 0.23 to 0.40, consistent with a 
substantially reduced risk of atopy in pertussis-vaccinated children. The same 
analysis in the subgroup of children attending orthodox reformed schools (39 
unvaccinated and 128 vaccinated children) yielded similar point estimates. For 
“any atopic disorder” the adjusted odds ratio (vaccinated /unvaccinated) was 
0.16 (CI95% 0.04 to 0.67, data not shown in table). 
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Table  Prevalence of atopic disorders among unvaccinated and vaccinated 
children and crude and adjusted odds ratios for atopic disorders 
(vaccinated/unvaccinated) with 95% confidence intervals (CI95%) 
 
 
  Allergy Eczema Asthma Any atopic 
disorder
  N % % % %
Unvaccinated 44 11.4 13.6 11.4 22.7
Vaccinated 1680 5.2 4.9 8.7 13.8
   
  OR OR OR             OR  
Crude  
Adjusted*  
CI95% 
 0.40
0.23
0.07 – 0.79
0.33
0.26
0.11 – 0.63
0.69 
0.40 
0.10 – 1.70 
0.51
0.37
0.16 – 0.87
 
*Variables included in the multivariate model were for 
allergy:  birth order, family size, year of birth, atopy of the father, 
age of mother at birth  
eczema: birth order, atopy of the father, age of mother at birth 
asthma: birth order, family size, year of birth, atopy of the father, 
age of mother at birth 
any atopy: birth order, family size, atopy of the father, age of mother 
at birth 
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Discussion 
In the present study we found that pertussis-vaccinated children were at a 
considerably lower risk of atopic disorders than unvaccinated children. Most 
vaccinated children received the combined DTP-polio vaccine. Hence, the 
comparison of children with and without pertussis vaccination was almost 
equivalent to the comparison of DTP-polio vaccination and no vaccination at all. 
Data used for this study were not collected to answer the present research 
question, and consequently no sample sizes for vaccinated and unvaccinated 
groups were computed. We found 44 unvaccinated children and the relations 
studied were significant. Adjustment for confounders could have been a problem 
with so few children at risk, with resulting empty cells and huge confidence 
intervals. However this was not the case and the results of the adjusted analyses 
showed similar relations. All data were collected retrospectively from files and 
possibly misreporting, most likely underreporting, of atopic diseases may have 
occurred. It could be that this misclassification is differential, i.e. related to the 
risk factor under study. This would for instance mean that parents of vaccinated 
children report less atopy than unvaccinated children. However, the relations 
found persisted, even became somewhat stronger when we performed the 
analyses in the more homogenous group of children attending orthodox reformed 
schools. Even if within this more homogenous group underreporting would be 
differential, it would be more likely that parents of unvaccinated children (more 
orthodox religious families) would report less than parents of vaccinated children. 
However, this bias would lead to an attenuation of the odds ratio and the 
unbiased odds ratio would even be more extreme.  
In the Netherlands pertussis is endemic in childhood with four-yearly peaks (12). 
The highest incidence is reported in infants younger than one year (35 per 
100,000 per year in the period 1989-1993). Pertussis cases are reported both in 
vaccinated and in unvaccinated children, the incidence in the latter group being 
roughly tenfold the incidence in the vaccinated group. The relatively low 
incidence in the unvaccinated group (compared to completely unvaccinated 
groups in Germany) can be explained by herd immunity.  
As only 0.7% of our study population was born after 1997, the role of acellular 
pertussis vaccine is negligible in this study.  
Given the hygiene hypothesis we would expect the immune system of the 
unvaccinated children to have shifted more towards the Th1-side, inconsistent 
with a raised risk of atopy. On the other hand, the immune system of vaccinated 
children is triggered with the (albeit killed) micro-organisms at a very young age 
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and from this point of view our findings do fit in the hygiene hypothesis and are 
biologically plausible.  
Our findings are consistent with a recent study in Germany by Grüber et al (7).  
Several studies found an increased risk of asthma and allergy in DTP- or 
pertussis-vaccinated children (1,2,3,4), but this may be due to residual 
confounding or confounding by indication as the reasons for not vaccinating are 
not described and may be related to the outcome. A number of studies found no 
relation between the DTP- or the pertussis-vaccination and atopy (5, 6, 8, 9). 
One of these is a randomized controlled trial (8) which compared three groups 
which received different cocktails of DTP with a control group which received DT 
only. However the age of evaluation was rather young: 2½ years, and this may 
account for the lack of an effect. Henderson et al (5) found no difference, but in 
this study the outcome was wheezing at the age of not more than 42 months. In 
all (but one) studies we are dealing with observational studies, and residual 
confounding cannot be excluded, especially when the reason for refraining from 
vaccination is not known. It is important for future studies to include groups 
which are as homogenous as possible and describe well the differences between 
vaccinated and unvaccinated groups. 
 
Conclusion 
Our results suggest that whole cell pertussis-vaccinated children have a lower 
risk of atopic disorders. However we cannot exclude that other vaccine 
components (diphtheria, tetanus, poliomyelitis) or other vaccinations played a 
role as well.  
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Abstract 
Background: Because the Haemophilus influenzae type b (Hib) vaccination was 
added recently to most existing vaccination programmes, no conclusive data on 
the relationship with atopic disorders are yet available. 
Study objective: To assess the relationship between Hib vaccination in the first 
year of life and reported physician-diagnosed atopic disorders at age 8-12 years. 
Method: Parents of 1201 children attending Orthodox Reformed (Protestant) 
primary schools in the Netherlands returned questionnaires reporting data on 
vaccination status, atopic symptoms and physician-diagnosed lifetime atopic 
disorders (asthma, hay fever, eczema and food allergy), and possible 
confounders. This study was conducted within the framework of a larger study on 
the relationship between the diphtheria-tetanus-pertussis-poliomyelitis (DTPPo) 
vaccination and reported atopic disorders. 
Results: The adjusted odds ratio of any atopic disorder (HiB 
vaccinated/unvaccinated) was 1.09 (CI95% 0.79 - 1.50). For asthma, hay fever, 
eczema and food allergy the results were respectively: 0.89 (CI95% 0.55 - 1.43), 
0.94 (CI95% 0.47 - 1.90), 1.09 (CI95% 0.75 - 1.58) and 0.68 (CI95% 0.38 - 1.19). 
Conclusion: In the Dutch population there is no indication for a higher risk of 
reported physician-diagnosed atopic disorders at primary school age after the Hib 
vaccination in the first year of life. 
 
Submitted
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Introduction 
The prevalence of atopic disorders has increased during the second half of the 
20th century and explanations for this are still being sougth. Because the highest 
prevalence is found in modern societies and is  increasing in those societies 
changing to a more modern lifestyle, elements of western lifestyle have been 
investigated, including childhood vaccination programmes. Such studies are also 
important because some countries a growing resistance to the childhood 
vaccination programmes, resulting in a declining vaccination coverage. Because 
serious infectious diseases have almost been eradicated, for part of the 
population possible adverse effects of vaccinations may take precedence over 
their preventive action. 
The possible effects of the measles-mumps-rubella vaccination (MMR) and 
the diphtheria-tetanus-pertussis vaccination on atopic disease have been well 
studied (1-5). However, less is known about the relationship between the 
Haemophilus influenzae type b (Hib) vaccination and atopic disorders. The few 
studies published so far (4, 6, 7) found no evidence of more atopy in Hib 
vaccinated children. In these (observational) studies, information bias, residual 
confounding and confounding by indication could not be excluded. Therefore we 
need more evidence concerning the Hib vaccination as a potential risk factor for 
atopic disorders. We analysed data of a study conducted to investigate the 
relationship between the diphtheria-tetanus-pertussis-poliomyelitis (DTPPo) 
vaccination and atopy in the Orthodox Reformed (Protestant) population in the 
Netherlands, which also collected data on the HiB vaccination. Some of the study 
population was born before, and some after the introduction of the Hib into the 
Dutch National Vaccination Programme (i.e. April 1 1993). 
Aim of the study 
To assess the relationship between Hib vaccination in the first year of life and 
reported atopic disorders at age 8-12 years. 
 
Methods 
Childhood vaccinations in the Netherlands 
According to the National Vaccination Programme, infants get four vaccinations of 
DTPPo and Hib in their first year of life. At 14 months children are immunized 
with the MMR and the meningococcal c vaccine (Neis Vax). At 4 years children 
receive a vaccination for diphtheria-tetanus-poliomyelitis (DTPo) and acellular 
pertussis (aP), and at 9 years DTPo and MMR. The Hib vaccination (administered 
at 2, 3 and 4 months) was introduced in April 1993 and the Neis Vax in 2003. 
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Consequently, part of the population under study did not regularly receive the 
Hib vaccination. The whole study population was offered the Neis Vax at age 7 
years or older. 
Study area, population and design 
The present study was conducted in the framework of an earlier study designed 
to assess the relationship between the DTPPo vaccination and reported atopic 
disease (5). Briefly, in 2003 and 2004, we sent questionnaires to 4480 children 
(aged 8-12 years) of 38 Orthodox Reformed (Protestant) primary schools in the 
Netherlands. Many parents of children attending these schools refuse 
vaccinations for religious reasons. A total of 1875 questionnaires (42%), of which 
1872 were suitable for analysis, were returned. The present study population 
comprised the 1201 children who all received the DTPPo vaccination; 41% of 
these children were born before April 1 1993 and therefore did not regularly 
receive the Hib vaccination in their first year of life. However, in the year before 
April 1993 it was possible to receive the Hib on special request.  
Data collection 
The questionnaire asked for symptoms and physician diagnosis of asthma, hay 
fever and eczema (ever) (Dutch translation of the ISAAC questionnaire (8, 9)), 
physician-diagnosed food allergy ever, childhood vaccinations, BCG vaccinations 
and influenza vaccinations, gender, passive smoking (prenatally, during the first 
year of life and currently), date of birth, perinatal data, birth order, ZIP code, 
year of birth of the mother, any atopic disorders of parents or siblings, family 
composition, education, income, living conditions (current and during the first 
year of life), day care attendance, breast feeding, nutrition during the past 
month, frequency of exercise, body height and weight, and having had common 
infectious diseases preventable by vaccinations (measles, mumps, rubella or 
pertussis). 
Statistical analysis  
The relationship between receipt of the Hib vaccination in the first year of life and 
asthma, hay fever, eczema, food allergy, and “any atopic disorder” (ever 
diagnosed by a physician, at least one of these diseases) was evaluated by 
means of logistic regression. Analyses were performed both in univariate and 
multivariate models. Potential confounders are shown in Table 1. A variable was 
included in the model if it changed the univariate point estimate by at least 10% 
(10).  
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Table 1 Potential confounders in the relationship between the Hib vaccination 
and atopic disorders 
 
Season of birth 
Birth order 
Gender 
Gestational age 
Birth weight 
Age of  the mother at the time of delivery 
Exposure to smoking (prenatally, during the first year of life and currently) 
Breast feeding for four months or more (yes/no) 
Housing in the first year of life (rural, living on a farm with livestock/rural other / 
city) 
Pet keeping (furry pets or birds yes/no) during the first year of life and currently 
Day care starting at age 6 months or less (yes/no) 
Current age 
Asthma and/or allergy of the parents and/or siblings 
Highest educational level of the parents 
Family income 
Current level of urbanization (five levels) 
Living on a farm with livestock (yes/no) 
Sibship size 
Mould in the child’s bedroom in the past year 
Frequent (more than five days/week) consumption of  
fruit (yes/no) 
(raw or cooked) vegetables (yes/no) 
anti-oxidants (yes/no) 
unskimmed dairy products (yes/no) 
wholemeal bread (yes/no) 
Frequent (at least one day/week) consumption of fish 
Frequent  exercise (school gym at least once a week and playing games with 
physical activity for at least half an hour a day and either being a  
member of a sporting club or walking or cycling from home to school vice 
versa for at least one hour a day) 
Body mass index 
MMR vaccination 
Pertussis vaccination
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  Because the question on income is a sensitive one which is often skipped, 
participants who did not answer this question were ranked according to income 
data linked to their ZIP code (11), and we imputed a code for income such that 
the total distribution of income remained the same as it was for the participants 
who did answer this question.  
 The Hib vaccination was first introduced in the Dutch National Vaccination 
Programme for the cohort born on April 1 1993; during one year before the 
official introduction it was available on special request. We assessed the risk 
factor in three different ways: 1) as reported, i.e. children whose parents 
indicated they did not know whether or not their child received the HiB 
vaccination in the first year of life were omitted from the analysis (main 
analysis), 2) all children with missing Hib vaccination status were categorized as 
“no” (i.e. did not receive the Hib vaccination in their first year of life), 3) all 
children with missing vaccination status and born before April 1 1992 were 
categorized as “no”, all other children of this group were categorized as “yes” 
(i.e. received at least one Hib vaccination in their first year of life).    
The main analyses were repeated taking the multi-level structure into 
account (level 1: children; level 2: families; level 3: schools).  
 SPSS version 11.0 and ML-win version 1.1 were used for all computations. 
A two-sided p-value of 0.05 or less was considered significant in all tests. 
Assessment of selection bias 
The method of evaluation of selection bias has been described elsewhere; we 
concluded that no selection on DTPPo vaccination status had occurred (5). 
 
Results 
Relationship between Hib and atopy 
Of the1201 children, 1070 (89.1%) reported their Hib vaccination status. Of 
these 1070 children, 652 (60.9%) reported that they had at least one Hib 
vaccination in the first year of life. Of these 652 Hib vaccinated children, 45 
(6.9%) indicated that they were incompletely vaccinated for Hib. Characteristics 
of the children, by Hib vaccination status, are presented in Table 2.  
 Table 3 shows prevalences, and univariate and multivariate ORs with 95% 
confidence intervals (CI95%) for the relationships between the Hib vaccination and 
atopic disorders. Atopy had a similar prevalence in Hib vaccinated and 
unvaccinated children (adjusted OR: 1.09 (CI95%=(0.79-1.50)). The separate 
disorders also showed (clinically and statistically) no significant differences. The  
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Table 2 Characteristics of study population (N=1201) by Hib vaccination status 
 
 Unvaccinated 
group * 
N=418        %   
Vaccinated 
group * 
N=652          % 
Vaccination 
status unknown 
N=131            % 
Gender Male 49.3 50.3 53.4
Year of birth 1990/1991
1992
1993
1994
1995/1996
Unknown
16.8
46.4
22.7
10.5
3.6
0.0 
2.0 
7.4 
26.9 
40.4 
23.2 
0.1 
14.5
35.9
20.6
21.4
7.6
0.0
Atopic disorders 
in parents  
and/or siblings 
Yes
No
Unknown
69.6
30.1
0.2
62.5 
36.8 
0.7 
64.9
35.1
0.0
Primary or less 0.5 0.4 0.0
Lower professional 
& lower secondary 
24.6 22.2 28.2
Medium 
professional
27.5 31.1 23.7
Higher secondary 15.1 14.9 16.0
High professional 
&  university 
32.1 31.0 31.3
Highest 
education of 
parents 
Unknown 0.2 0.4 0.8
Number of 
children 
in the family 
1
2
3
4
5+
Unknown
0.2
8.9
25.8
24.2
40.7
0.2
1.8 
18.5 
33.8 
21.6 
24.1 
0.1 
1.5
14.5
23.7
26.0
34.4
0.0
Pertussis part of 
DTPPo first year 
 
Yes
No
Unknown
89.2
6.0
4.8
91.9 
2.5 
5.7 
84.0
3.8
12.2
MMR at 14 
months 
Yes
No
Unknown
80.6
17.7
1.7
95.1 
3.2 
1.7 
88.5
5.3
6.1
Reported infections: 
Pertussis 
 
Mumps 
 
Measles 
 
Rubella 
Yes
Yes
Yes
Yes
8.4
5.0
26.6
7.7
10.1 
 
1.8 
 
12.7 
 
5.2 
4.6
1.5
20.6
9.2
*Unvaccinated means no Hib vaccination in the first year of life; vaccinated 
means at least one Hib vaccination in the first year of life 
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Table 3 Physician diagnosed atopic disorders for (Haemophylus influenzae type 
b) vaccinated children and unvaccinated children (children who reported Hib 
vaccination status, N=1070): prevalences (%) and crude and adjusted (adj) odds 
ratios (OR) (HiB+/HiB-) with 95% confidence intervals (CI95%) 
 
 
  % OR AdjOR CI95% 
Asthma Vaccinated
Unvaccinated
Unknown
11.0
13.6
7.8
0.79 0.89 0.55-1.43 
Hay fever Vaccinated
Unvaccinated
Unknown
5.1
6.3
5.4
0.81 0.94
 
0.47-1.90 
 
Eczema Vaccinated
Unvaccinated
Unknown
23.5
22.8
18.6
1.04 1.09
 
0.75-1.58 
 
Food allergy Vaccinated
Unvaccinated
Unknown
7.3
9.8
5.4
0.72 0.68
 
0.38-1.19 
 
Any atopic disorder Vaccinated
Unvaccinated
Unknown
33.9
35.7
28.6
0.93 1.09
 
0.79-1.50 
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results of the analyses with the two alternative assessments of the risk factor 
show similar nonsignificant relationships (data not shown).  
Multilevel analysis of the multivariate models presented in Table 3 yielded similar 
results (data not shown).  
Validation of the risk factor 
We compared the reported Hib vaccination of 74 children with the officially 
registered vaccination data; disagreement emerged in five of these cases (6.8%).  
 
Discussion 
In the present study no significant relationship was found between Hib 
vaccination in the first year of life and physician-diagnosed atopic diseases in 
primary school children. Our study population was a homogeneous group of 
primary school children (all adhering to the same religious group), all of whom 
were DTPPo vaccinated. In this study, the main reason for not being vaccinated 
for Hib is that this vaccination had not yet been introduced in the National 
Vaccination Programme until 1993. This implies that probably only age was a 
confounder (for which we adjusted in the analyses). However, data on the MMR 
vaccination coverage in the two groups (Hib vaccinated and Hib unvaccinated) 
indicate that some of the Hib unvaccinated group may be those with fundamental 
objections to vaccinations, but nevertheless accepted the DTPPo for fear of 
serious diseases.  The relationship studied pertains to a possible additional risk to 
other childhood vaccinations. 
The relationships found in our study are similar to, or even weaker than 
those reported earlier (4, 6, 7), thus confirming the conclusion that there is no 
indication for a higher risk of atopic disorders in Hib vaccinated children.  
Histories of infections of pertussis, mumps, measles and rubella were not 
included in the main multivariate model because these are obviously intermediate 
variables in the relationship between the respective vaccinations and atopy. 
Moreover, reverse causation could also play a role because children predisposed 
to allergic disease may have a different antiviral immunity (13).  
Limitations of the study 
Reliability of the risk factor: 6.8% (5 of 74 children) of the answers on the 
question about the Hib vaccination did not agree with the official registrations. 
This uncertainty may be because the Hib was only introduced in 1993. Therefore 
some misclassification cannot be excluded and this (non-differential) 
misclassification may have diluted the effect estimates. Moreover, a  relatively 
large number of parents (10.9%) did not answer the question on Hib vaccination. 
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However, we used different approaches to allocate these children to one of the 
two groups (vaccinated or unvaccinated), and all approaches led to similar 
conclusions. Thus, we argue that the findings are relatively robust. 
Allergic rhinitis: Because our questionnaire did not include questions on allergic 
rhinitis, a number of allergic cases may have been missed in both groups. 
External validity: This study was conducted in a relatively homogeneous group of 
people, all from a common cultural background. Although this is a strong aspect 
of the study design, it could at the same time raise questions about the 
generalizability of the conclusions. However, there is no reason to assume that 
the study population differs biologically from the general Dutch population such 
that childhood vaccinations would have a different impact on atopy.  
In conclusion, we found that there is no indication for a higher risk of reported 
physician-diagnosed atopic disorders due to the Hib vaccination in addition to 
other childhood vaccinations in the Dutch population.  
 
Acknowledgements 
We thank the following people, institutions and authorities for their kind 
cooperation: 
Schools for their participation. 
Children and parents for filling out questionnaires and donating blood. 
Kris Sieradzan (Erasmus MC Rotterdam, Dept. of Neurology) for preparing and 
scanning the questionnaires. 
Marlies Luijten (Erasmus MC Rotterdam, Dept. of General Practice), Barend 
Nagelkerke and Tom Nagelkerke for logistic support. 
The Departments of Youth Health Care of the following District Health 
Services for providing vaccination rates and/or co-signing letters of invitation: 
 GGD Midden-Holland 
 GGD Noordwest-Veluwe 
 GGD Regio Stedendriehoek 
 GGD Rotterdam e.o. 
 GGD Zeeland 
 GGD Zuidhollandse Eilanden 
 GGD Zuid-Holland West 
 GGD Zuid-Holland Zuid 
The following Vaccination Registries for providing vaccination data: 
 Stichting Provinciale Entadministratie Gelderland 
 Afdeling Entadministratie, GGD Rotterdam e.o. 
 64
References 
1. Koppen S, De Groot R, Neijens HJ, Nagelkerke N, Van Eden W, Rumke HC. No 
epidemiological evidence for infant vaccinations to cause allergic disease.  
Vaccine 2004;22:3375-85.  
2. Bernsen RM, van de Wouden JC. Re: No epidemiological evidence for infant 
vaccinations to cause allergic disease. Letter to the Editor. Vaccine 
2005;23:1427. 
3. Bernsen RM, de Jongste JC, van der Wouden JC. Lower risk of atopic 
disorders in whole cell pertussis-vaccinated children.  Eur Respir J 
2003;22:962-4. 
4. Mommers M, Weishoff-Houben M, Swaen GM, Creemers H, Freund H, Dott W, 
van Schayck CP. Infant immunization and the occurrence of atopic disease in 
Dutch and German children: a nested case-control study. Pediatr Pulmonol 
2004;38:329-34. 
5. Bernsen RM, de Jongste JC, Koes BW, Aardoom HA, van der Wouden JC. The 
diphtheria tetanus pertussis poliomyelitis vaccination and reported atopic 
disorders in primary school children. Submitted. 
6. Laubereau B, Grote V, Holscher G, Holscher B, Frye C, Wichmann HE, 
Heinrich J. Vaccination against Haemophilus influenzae type B and atopy in 
east German schoolchildren. Eur J Med Res 2002;7:387-92. 
7. DeStefano F, Gu D, Kramarz P, Truman BI, Iademarco MF, Mullooly JP, 
Jackson LA, Davis RL, Black SB, Shinefield HR, Marcy SM, Ward JI, Chen RT; 
Vaccine Safety Datalink Research Group. Childhood vaccinations and risk of 
asthma. Pediatr Infect Dis J 2002;21:498-504. 
8. Asher MI, Keil U, Anderson HR et al. International Study of Asthma and 
Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 
1995;8:483-91. 
9. Anyo G, Brunekreef B, de Meer G, Aarts F, Janssen NA, van Vliet P. Early, 
current and past pet ownership: associations with sensitization, bronchial 
responsiveness and allergic symptoms in school children. Clin Exp Allergy 
2002;32:361-6. 
10. Rothman K. Modern Epidemiology. Philadelphia: Lippincott-Raven 1998: 256-
7. 
11. Kerncijfers vierpositie postcodegebieden. Voorburg/Heerlen: Centraal Bureau 
voor de Statistiek 1995. 
12. Rubin DB, Schenker N. Multiple imputation in health care databases: an 
overview and some applications. Stat Med 1991;10:585-98. 
 65
13. Copenhaver CC, Gern JE, Li Z, Shult PA, Rosenthal LA, Mikus LD, Kirk CJ, 
Roberg KA, Anderson EL, Tisler CJ, DaSilva DF, Hiemke HJ, Gentile K, 
Gangnon RE, Lemanske RF Jr. Cytokine response patterns, exposure to 
viruses, and respiratory infections in the first year of life. Am J Respir Crit 
Care Med 2004;170:175-80. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
5 
 
Birth order and sibship size 
as independent risk factors  
for asthma, allergy, and eczema 
  
 
 69
Abstract 
Study objective: To disentangle the independent relations of birth order and 
sibship size with the presence of asthma, allergy and eczema. 
Method: In a retrospective study, 700 families in the Netherlands were selected 
with index children born in 1988-1990. Data were extracted from reports of 
health examinations at the age of 6 years of these children and their siblings. 
Results: Birth order, and not sibship size, appeared to be a strong risk factor for 
allergy (excluding eczema). Children with higher birth order had a lower risk of 
allergy compared to first-borns (adjusted odds ratios: 0.43, 0.26 and 0.05 for 
second-, third- and fourth- or higher borns, respectively; p<0.0001). Allergy 
including eczema also had a significant relation with birth order (p=0.001). For 
asthma there appeared no clear relation with birth order. For asthma a non-
significant relationship with sibship size (adjusted for birth order) was found 
(p=0.06): first-born children in small sibships were more at risk than those in 
larger sibships. For allergy and eczema no such trend was observed. 
Conclusion: Birth order is inversely related to the risk of allergy, independent of 
the size of the sibship. 
 
Keywords: asthma, allergy, eczema, sibship size, birth order. 
 
Pediatr Allergy Immunol 2003;14:464-9. 
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Introduction 
The prevalence of asthma and allergy has increased during the past decades and 
much effort has been put into identifying risk factors for these disorders, 
including elements of western lifestyle. Golding and Peters were the first to 
describe the protective effect of sibship size for eczema and hay fever (1). Since 
1986 many studies have demonstrated a lower prevalence of atopic disease in 
large families (2). There has been much speculation on the mechanism 
underlying this “sibling effect”. According to the hygiene hypothesis, a reduced 
opportunity of cross-infection in small families could increase the risk of hay fever 
(3, 4). Also,  prenatal mother-child interactions might be different after multiple 
births (5, 6). 
The proportion of allergy cases attributable to the sibling effect is 
approximately 30% (2). Hence, identification of the underlying mechanism is 
potentially important. However, different definitions of the sibling effect have 
been used, relating allergy to the number of older siblings, birth order, family 
size, the number of younger siblings and sibship size. Several definitions are 
(almost) equivalent: the number of older siblings and birth order are equivalent, 
because birth order equals the number of older siblings plus one; sibship size 
parallels family size; and sibship size minus the number of younger siblings 
equals the number of older siblings plus one. Therefore it suffices to study the 
role of birth order and sibship size as risk factors for atopic disease. However, it 
is difficult to disentangle the  effects of these two factors (7). In any random 
sample of individuals the two variables are strongly correlated, and including 
them both into a regression model would not yield a definite answer, unless both 
effects are assessed within families.  To examine all children in a family at a fixed 
age in a prospective study would be difficult because maturation of the increasing 
sibship may take a long time. Therefore, we performed a retrospective study 
investigating within families the independent role of birth order and sibship size 
as determinants for asthma, allergy and eczema at the age of 6 years.  
 
Methods 
Study area and population 
In the Netherlands all children fall under the auspices of a Municipal Health 
Service, which invites them for health examinations by a physician at the age of 
6 years. Parents are requested to fill out a questionnaire with details on their 
child’s health. Reports of these examinations are stored in a file together with the 
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questionnaire and data from birth up to the last examination in secondary school, 
including letters from specialists after referrals. Files are kept at the Service for 
about 25 years. We focused on the municipality of Zwijndrecht, a town south of 
Rotterdam with over 40,000 inhabitants. From the files of the Municipal Health 
Service of Zwijndrecht, 700 families with at least two children with a written 
report of a check-up at the age of 6 years were randomly selected. At least one 
of the children in the family had to be born in 1988, 1989 or 1990. 
Sample size calculation 
We assumed a prevalence of allergy of 10% in first-born children and 5% in their 
siblings. In order to detect this difference with a power of 0.80 and alpha=0.05 a 
sample size of 700 families was required. 
Data extraction 
From the files the following data were extracted: current asthma, allergy, eczema 
(as recorded by the physician who did the check-up; in the questionnaire or 
mentioned in letter(s) from a paediatrician/pulmonologist), current medication, 
birth order, sibship size, date of birth, gender, date of check-up, year of birth of 
the mother, postal code, country of birth of the parents, occupation of the bread-
winner, atopic disorders of the parents, diphtheria tetanus pertussis poliomyelitis 
(DTPP) vaccination status and duration of breast-feeding. 
Blinding 
To avoid possible bias the researcher (RMDB) classified children as being 
asthmatic, allergic or having eczema only if this was explicitly mentioned in the 
file by the physician who did the check-up or by a paediatrician or other specialist 
in a letter preserved in the file. In case of doubt the researcher consulted one of 
the Municipal Health Service’s physicians who was blind for the risk factors under 
study.  
Derived variables 
The following variables were derived from data extracted from the files: 
- age of the mother at the time of delivery. 
- level of urbanization derived from the zip code (8). Because of the 
homogeneity of urbanization in the study area, two levels were recognized: 
heavily urbanized and moderately urbanized. 
- level of occupation using the classification system of the Statistics 
Netherlands (9). Occupation was categorized into 5 levels: elementary, low, 
average, high, academic. In case of  missing occupation, we estimated the  
level of occupation as follows: first (for all patients with known occupation) 
the mean income per bread-winner, derived from the ZIP code,(8) was used 
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as predictor in a linear regression model with level of occupation as outcome 
variable (after checks of assumptions); for cases with “occupation” missing 
the mean income per bread-winner was imputed from  this linear equation.  
- country of origin; a dichotomy was used: both parents born in the 
Netherlands (yes/no). 
- season of birth divided in three categories: June-September, October-January 
and February-May (10-12). 
- Breast feeding for one month or more. This cut-off point was chosen because 
it has been observed by Sears et al (13) that children who were breastfed for 
less than one month have a risk of asthma and allergy similar to those who 
are not breastfed at all. 
Statistical analysis 
The independent relation of birth order and sibship size with asthma, allergy 
(including house-dust mite, pollen, furry pets, hay fever, rhinitis, excluding food 
allergy and eczema) eczema (including food allergy), allergy (including 
eczema/food allergy), and any atopic disorder (asthma, allergy, and/or eczema) 
was evaluated within families by means of logistic regression for repeated 
measurements (Generalized Estimating Equations) (14), families being the units 
of analysis, which takes correlation between family members into account (SAS 
PROC GENMOD). Analyses were performed both in univariate and multivariate 
models with adjustments for sibship size or birth order (depending on which 
model was applicable) and the subset of the following variables which changed 
the univariate point estimate by at least 10% (15): year of birth, season of birth, 
gender, age at the time of check-up, asthma, allergy and/or eczema of the 
parents, level of occupation of the bread-winner, age of  the mother at the time 
of delivery, level of urbanization, country of origin and DTPP vaccination status. A 
two-sided p-value of 0.05 was considered significant. For the two main risk 
factors (birth order and sibship size) also tests for linear trend were performed. 
We performed the multivariate analyses both with and without “breast-feeding 
for one month or more” in the model, as the causal pathway between breast-
feeding and atopy is unclear, and may be in two directions: breast-feeding may 
have implications for the development of atopic disorder (13, 16), but on the 
other hand children who are at risk of developing an atopic disorder are more 
likely to have been breast fed. 
The SPSS (version 10) and SAS (version 6.12) programs were used for all 
analyses. 
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Results 
Data were obtained of 1961 children from 700 families. For 1727 of these 
children (88%) a health check-up file was available. The average age at which 
the health check-up was performed was 5.9 years (sd 0.6 years). 246 children 
(14%) reported at least one of the atopic disorders under study. Allergy has a 
strong relation with birth order: adjusted odds ratios 0.43, 0.26 and 0.05 for 
second-, third- and fourth- or higher borns, respectively (first-borns reference 
category); p-value for trend < 0.0001. Only sibship size was included in the 
multivariate model. Also allergy according to the more comprehensive definition 
(including eczema and food allergy) showed a clear relation with birth order 
(adjusted odds ratios 0.47, 0.35 and 0.39, p-value for trend=0.001). The odds 
ratio for birth order four and higher is somewhat raised due to more eczema in 
this category). For asthma there appeared no clear inverse relation with birth 
order. For none of the five outcome variables did addition of sibship size to the 
model substantially change the odds ratios for birth order. Table 1 lists the 
characteristics of the 700 families, table 2 gives data on their 1,961 children, and 
table 3 presents data on the health examinations. Table 4 shows prevalences, 
odds ratios and adjusted odds ratios for asthma, allergy (without food allergy and 
eczema), eczema (including food allergy), allergy (including eczema/food 
allergy), and any atopic disorder, by birth order. 
Sibship size was not strongly related to the outcome variables. Only 
asthma seems to be less prevalent in larger families (after adjustment for birth 
order, age of the mother and age at the time of the check-up), although the 
relationship is not significant (p-value for trend: 0.06). For first-borns the 
prevalences of asthma were 10%, 7%, 6%, and 3% in families with 2, 3, 4, and 
5 or more children, respectively (data not in table). Table 5 presents results by 
sibship size. 
Inclusion of breast-feeding in the multivariate model made no difference 
to these outcomes. 
 
Discussion 
It is generally assumed that birth order is a risk factor for allergy but as yet no 
within-family study has demonstrated its effect independent of sibship size. We 
found that birth order, but not sibship size, is a risk factor for allergy. Our data 
show no relationship between birth order and asthma; however, there seems to 
be a lower prevalence of asthma in larger families, especially after adjustment for  
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     Table 1 Data on 700 families with two or more children, 
     one of which born in  1988-1990      
  N % 
Sibship size (no. of children) 2 368 53 
3 210 30 
4 73 10 
5-9 49 7 
Country of origin The Netherlands 606 87 
Other 94 13 
Mother atopic/asthmatic Yes 103 15 
No 590 84 
Unknown 7 1 
Father atopic/asthmatic Yes 68 10 
No 625 89 
Unknown 7 1 
Occupation level Elementary 23 3 
Low 104 15 
Average 467 67 
High 73 10 
Academic 33 5 
Urbanization Heavily urbanized 339 49 
Moderately urbanized 358 51 
Unknown 3 0 
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Table 2 Data on the 1,961 children in the study 
 N % 
Birth order 1 708 36 
2 711 36 
3 330 17 
4 128 7 
5-9 71 4 
Year of birth 1969-75 17 1 
1976-80 53 3 
1981-85 270 14 
1986-90 1085 55 
1991-95 455 23 
1996-2000 77 4 
Unknown 4 0 
Season of birth June-September 619 32 
October-January 553 28 
February-May 633 32 
Unknown 156 8 
Gender Male 1011 52 
Female 944 48 
Unknown 6 0 
Age (years) of mother at delivery <26 400 20 
26-30 809 41 
31-35 567 29 
>35 149 8 
Unknown 36 2 
Breast-feeding >1 month Yes 896 46 
No 753 38 
Unknown 312 16 
DTPP vaccination Yes 1730 88 
No 46 2 
Unknown 185 9 
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Table 3 Data on health check-ups at age 6 years in 1,727 of the 1,961 children 
included in the study 
 N %
Health check-up file Available 1727 88
Not available 234 12
 
Data on 1727 children with available health check-up records: 
 
Asthma Yes 153 9
No 1574 91
Allergy* Yes 77 4
No 1650 96
Eczema and food allergy Yes 106 6
No 1623 94
Allergy, incl. food allergy and eczema Yes 160 9
No 1567 91
    
Asthma and/or any allergy and/or  Yes 246 14
Eczema No 1481 86
 
  Mean (sd)
Age (years) at check-up 1727 5.9 (0.6)
 
*  including: hay fever, rhinitis, house dust mite allergy, pet allergy, excluding food allergy/eczema 
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birth order, implying that first-borns in small families have a  higher prevalence 
of asthma than first borns in large families.  An explanation for this phenomenon 
could be that parents decide not to plan for more children if a serious disease in 
their first child becomes manifest.   
We found a risk of eczema and food allergy for children with birth order 
four and higher which was higher than the risk for birth order two and three. We 
wondered whether this might be due to a different awareness over time (of 
doctor or parents). We therefore checked whether there was a raised risk of 
(diagnosis of) eczema over time by considering the fraction of eczema reporteded 
for each year of check-up for first borns and for second borns separately. This did 
not reveal any time dependent pattern. We can not explain our finding.  
Three other studies have investigated the relationship between birth order 
and atopy within families (17,18,19). Two of these (17,18) selected families with 
at least one atopic child and did not consider the relationship between sibship 
size and atopy. The third study (19)  evaluated the relationship between atopic 
disease and number of older siblings in a cross-sectional design, but evaluated 
children at different ages. After adjustment for other family characteristics 
(including  “number of younger siblings” which is almost equivalent to 
adjustment for sibship size), they found a protective effect of high birth order 
only in children with atopic fathers. Our data do not confirm this finding: the 
relationship in children of non-atopic fathers was even somewhat stronger than in 
children of atopic fathers. 
In the Netherlands the proportion of first borns has risen from 27% in 
1950 to 45% in 1990, whereas the proportion of fourth (and higher) borns was 
31% in 1950 and 7% in 1990 (20).  If we assume that the prevalences and odds 
ratios for allergy (excl. eczema/food allergy) found in this study apply to the 
period from 1950 to 1990 and that children without siblings (a category we did 
not consider) have the same risk as first-borns in larger sibships, the increase of 
allergy during these years due to this reduced family size would be 41%. 
We considered it unlikely that breast-feeding is just a confounder. The 
causal path between atopy and breast-feeding is probably in two directions: 
breast-feeding may have implications for atopy (13, 16), but on the other hand 
mothers of children at risk may be recommended to start or continue breast-
feeding. Therefore, we analysed our data with and without “breast-feeding for at 
least one month” in the multivariate model. Adjustment for breast-feeding 
resulted in similar odds ratios. Breast-feeding appeared protective for asthma 
(6% vs 12%) and for any atopic disorder (12% vs 17%). Thus, if we could 
 80
eliminate this “confounding by indication”, the protective effect might be even 
larger.  
Misclassification 
The data of this study are extracted from routinely collected records, and 
inaccurate reporting or underreporting of the disorders under study may have 
occurred. The prevalences of 9%, 4%, 6% and 14% for asthma, allergy, eczema 
and any atopic disease, respectively, suggest that there may be limited 
underreporting as higher prevalences have been published for the period most of 
the children in our study had their health examination (21, 22). This does not 
necessarily invalidate our findings, as misclassification is unlikely to be 
differential, i.e. related to birth order or sibship size. An increased underreporting 
of disease with increasing birth order (the mother “getting used” to diseases of 
her children) would  explain the lower prevalence in children with higher birth 
order. However, results of an unpublished study conducted in 1998/1999 by 
physicians of the Municipal Health Service, where we extracted the data, suggest 
that there is no need for this concern (personal communication H. Aardoom, May 
2002). They asked the accompanying parent of 400 children during the health 
check-up to fill out the ISAAC questionnaire for asthma symptoms (23). Self-
reporting slightly increased with increasing birth order and increasing sibship 
size. 
These routinely collected records inevitably have limitations. They did not 
provide information on relevant conditions in the child’s early life, apart from 
breast feeding. One can argue that these conditions usually don’t change 
dramatically within families. On the other hand, a change in smoking habits or 
disposal of pets in case of an allergic first born can not be excluded. 
In conclusion, we demonstrated that birth order is inversely related to the 
risk of allergy, independent of the size of the sibship. However, it is still a 
question whether (within families) the reduced risk of later born children is due to 
an increased exposure to pathogens or to a with increasing parity changing 
prenatal mother-child interaction. Further research is needed to detect which 
antenatal and/or environmental factors explain this relationship. The answer to 
this question could help us in the prevention of atopic disorders. 
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Abstract 
Background: Considerable effort has been put into identifying early 
determinants for atopic disorders. Many studies have evaluated the role of foetal 
development and obstetric complications. However, the results are not 
unequivocal.  
Study objective: To assess the relationship between perinatal characteristics 
and obstetric complications, and the presence of reported current asthma, allergy 
and eczema at the age of six years in the framework of a previously conducted 
study.  
Method: 700 families in the Netherlands with index children born in 1988-1990 
were retrospectively selected. Data were extracted from the Municipal Health 
Service’s records of health examinations of these children and their siblings. 
These examinations were carried out at the age of six years. The records 
contained data on reported atopic disorders and perinatal characteristics. 
Results: Gestational age was inversely related to the risk of asthma (p for trend: 
0.03). Children with low birth weight tended to have a lower risk of any allergy, 
albeit not significant (p=0.07). However, no link was found between neonatal 
head circumference and atopic disorders. The ratio of neonatal head 
circumference to birth weight was positively associated with the risk of atopic 
disorders, especially with the risk of asthma (OR=1.87 CI95% = [1.11, 3.15]). 
Vacuum extraction was a risk factor for allergy (OR=1.84, CI95% = [1.03, 3.28]), 
but not for asthma. Induced labour was positively associated with the risk of 
inhalant allergy (OR=2.22, CI95% = [1.09, 4.51]) and, to a lesser extent, asthma 
(OR=1.72, CI95% = [0.95, 3.10]). For caesarean section and forcipal extraction 
there were no such relationships. 
Conclusions: Prematurity is a risk factor for asthma reported at six years. A 
high ratio of head circumference to birth weight is a risk factor for any atopic 
disorder. Vacuum extraction was associated with a higher risk of allergy, and 
induced labour is a risk factor for inhalant allergy. All results should be viewed 
with the possibility of residual confounding. 
 
Keywords: Gestational age, birth weight, neonatal head circumference, asthma, 
allergy, eczema. 
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Introduction 
The prevalence of asthma and allergic disorders has increased over the past 
decades and much effort has gone into identifying risk factors for these disorders. 
The relationship between fetal development and obstetric complications with 
childhood asthma and atopic disorders has been studied extensively (1-27). 
Results are not unequivocal: although several studies have reported that low 
gestational age (or low birth weight) is a risk factor for the development of 
subsequent asthma (3, 4, 6, 11, 20, 21), others could not confirm this 
relationship (8, 10, 13, 16, 27). Similarly, although some studies have found a 
link between high gestational age (or high birth weight) and either a high risk of 
asthma, atopic disease or a high IgE concentration (5, 9, 16, 21), other studies 
have not (7, 8, 12, 13). A positive association between neonatal head 
circumference and total IgE concentration was first reported in 1994 (5) and 
confirmed by others (12-14). This finding raised the hypothesis that this positive 
association might reflect the long-term effect of sustaining fetal brain growth at 
the expense of the trunk, in particular the thymus (5). More recently, this 
hypothesis was challenged by the finding that thymus size is not related to 
allergic disease (18) and that the relationship between the ratio of head 
circumference to birth weight and hay fever is negative (24).  
Several studies found that caesarean section is a risk factor for 
subsequent development of asthma (15, 19, 20, 23, 26) and allergic disease (18, 
23, 24), although this last result was not confirmed by Xu et al (19). Other 
complications during labour (vacuum extraction, forcipal extraction and induced 
labour) were also found to be positively related to the risk of asthma (15, 20).  
Within the framework of a retrospective study of  birth order and sibship 
size as risk factors for reported asthma, allergy, and eczema in children (28) we 
recorded various perinatal characteristics (gestational age, birth weight and 
neonatal head circumference) and obstetric complications. Because of the lack of 
consensus mentioned above, we aimed to contribute a piece of evidence to the 
bulk of results that already exists. The current study focused on the relationships 
between perinatal characteristics and obstetric complications on the one hand 
and asthma, allergy, and eczema as reported during health examinations at age 
six years on the other.  
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Methods 
Study area and population 
Population, sample size calculation and blinding have been described in detail 
elsewhere (28). Briefly,  data on health check-ups in children of 700 families 
were extracted from the files of a Municipal Health Service in the Netherlands. 
Only families with at least two children were included and index children were 
born in 1988-1990. The files contained health data from birth up to the 
examination at the age of six years. These examinations are approximately 
monthly during the first year of life, but primary school children get only one 
routine comprehensive examination at six years. 
Data extraction 
All data, including those on current atopic disorders, were extracted from the 
records as reported by the physician who did the check-up, or as reported in a 
questionnaire filled out by the parents, or as reported in letter(s) from a 
paediatrician/pulmonologist that was included in the file. The following items 
were extracted: gestational age, birth weight, neonatal head circumference, 
obstetric complications (such as caesarean section, vacuum extraction, forcipal 
extraction and induced labour), birth order, sibship size, date of birth, gender, 
year of birth of the mother, ZIP code, parents’ country of birth, breadwinner’s 
occupation, atopic disorders in the parents, diphtheria tetanus pertussis 
poliomyelitis (DTPP) vaccination status and duration of breast-feeding, diagnosis 
of current asthma, allergy, eczema and specific medication for these disorders at 
the age of six years and date of check-up. Length at birth was also recorded in 
the files, but we did not use this characteristic, as it is an unreliable measure 
(29).  
Statistical analysis 
We evaluated the relationship between perinatal characteristics (gestational age, 
birth weight, neonatal head circumference and the ratio of neonatal head 
circumference to birth weight) and obstetric complications (caesarean section, 
vacuum extraction, use of forceps, induced labour) on the one hand and, on the 
other, reported asthma, inhalant allergy (including house-dust mite, pollen, furry 
pets, hay fever, rhinitis), eczema (including food allergy), allergy (inhalant 
allergy and/or eczema), and any atopic disorder (asthma and/or allergy). 
Gestational age was categorized as follows: <36 weeks, 36-<41 weeks and ≥41 
weeks. Birth weight was categorized in <2500 grams, 2500-<4500 grams and 
≥4500 grams, head circumference in <37 cm and ≥37 cm, and the ratio of head 
circumference and birth weight in below the median and greater than or equal to 
 88
the median. The analysis was carried out within families by means of logistic 
regression for correlated measurements (Generalized Estimating Equations) (30). 
With this technique correlation between family members is taken into account. 
Analyses were performed both in univariate and multivariate models with 
adjustments for the subset of the following possible confounders which changed 
the univariate point estimate by at least 10% (31): sibship size, birth order, year 
of birth, season of birth, gender, age at the time of check-up, atopic disease of 
the parents, level of occupation of the bread-winner, age of  the mother at the 
time of delivery, level of urbanization, country of origin and DTPP vaccination 
status. For the relationships with obstetric complications we also considered 
gestational age, birth weight, neonatal head circumference and the ratio of 
neonatal head circumference to birth weight as possible confounders. However, 
because obstetric complications are likely to be intermediate variables in the 
relationship between perinatal data and atopic disorders, these complications 
were not considered as confounders. Similarly, in the relationships between 
perinatal data and atopic disorders, we did not consider the remaining perinatal 
data as confounders, because these variables are very likely to be strongly 
correlated and including them in the model could obscure possible relationships. 
A two-sided p-value of 0.05 was considered significant. For the risk factors with 
more than two categories (gestational age and birth weight) we also performed 
tests for linear trend. Breast-feeding was excluded from the model for two 
reasons: Firstly, the causal pathway between breast feeding and atopy is unclear, 
and may be in two directions: breast-feeding may have implications for the 
development of atopic disorders (32, 33), but on the other hand mothers of 
children who are at risk of developing an atopic disorder are commonly advised 
to breastfeed (34); secondly, breast-feeding may act as an intermediate variable 
in the relationship between perinatal factors and allergic disorders: adjustment 
for this variable could conceal any of the relations studied. 
For many children one or more of the perinatal characteristics was missing 
and consequently sometimes an adjusted analysis became problematic. In case 
no adjusted analysis was feasible we used a multiple imputation technique with 
five imputed data sets (35). Analyses were carried out for these five sets and 
results were pooled. Imputation was done with IVEware version 2.0. For all other 
analyses SPSS (version 11) and SAS (version 8.2) were used. 
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Results 
Data were obtained on 1,961 children from 700 families. At least one atopic 
parent was present in 150 families (21%); of 606 families (87%) both parents 
were born in the Netherlands. Health check-up data at the age of six years were 
available for 1,727 of the children (88%). The average age at which the health 
check-up was performed was 5.9 years (sd 0.6 years). Gestational age was 
recorded for 1,666 children (85%), birth weight for 1,710 children (87%) and 
neonatal head circumference for 861 children (44%). For 246 children (14%) at 
least one of the atopic disorders under study was reported.  
For further details of the 700 families and their 1,961 children we refer to a 
previous publication on this study (28). Perinatal characteristics and obstetric 
complications are presented in table 1, data on the health examinations at age 
six in table 2.  
Relations of perinatal data and atopy 
Table 3 shows the relationships (prevalences, ORs and adjusted ORs) between 
the perinatal data and asthma, inhalant allergy, eczema, any allergy, or any 
atopic disorder. 
Gestational age was inversely related to the risk of asthma (p for 
trend:0.03): children born after a gestational period of less than 36 weeks had a 
higher risk of asthma (OR=2.03, CI95% = [1.03, 4.01]), whereas children born 
after a gestational period of 41 weeks or more had a lower risk (OR=0.71, CI95% 
= [0.44, 1.14]) .  
Children with low birth weight tended to have a lower risk of allergy 
compared to children with normal birth weight, although the relationship was not 
significant (p=0.07). This relationship was of similar magnitude in the subgroup 
of children of normal gestational age (data not shown).  
Neonatal head circumference showed no significant relationships with the 
outcome variables. However the ratio of neonatal head circumference to birth 
weight showed a significant relationship with atopic disorders: children born with 
a large head circumference relative to their weight had a higher risk of asthma 
and “any atopic disorder”.   
Obstetric complications 
After adjustment for confounders neither caesarean section nor forcipal 
extraction were related to the outcome variables (table 4). However, vacuum 
extraction was related to a higher risk of allergy, whereas induced labour was 
associated with a higher risk of inhalant allergy. There was some evidence of a  
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Table 1  Perinatal data and obstetric complications 
 N % 
Perinatal data   
Gestational age < 36weeks 
36-< 41weeks 
≥ 41weeks 
Unknown 
62 
1250 
354 
295 
3 
64 
18 
15 
Birth weight < 2500gr 
2500-< 4500gr 
≥ 4500gr 
Unknown 
81 
1601 
28 
251 
4 
82 
1 
13 
Neonatal head circumference  < 37cm 
≥ 37cm 
Unknown 
788 
73 
1100 
40 
4 
56 
Ratio head circumference to 
birth weight (cm/gr)  
(median=0.01015) 
< median 
≥ median 
Unknown 
429 
432 
1100 
22 
22 
56 
Obstetric complications   
Caesarean section Yes 
No 
Unknown 
85 
1627 
249 
4 
83 
13 
Vacuum extraction Yes 
No 
Unknown 
92 
1620 
249 
5 
83 
13 
Forcipal extraction Yes 
No 
Unknown 
26 
1686 
249 
1 
86 
13 
Induced labour  Yes 
No 
Unknown 
129 
1583 
249 
7 
81 
13 
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Table 2 Data on health check-ups at age 6 years in 1,727 of the 1,961 children 
included in the study 
 N % 
    
Health check-up file Available 1727 88 
 Not available 234 12 
 
Data on 1,727 children from available health check-up records: 
 
Asthma                                   
 
Yes
No
153
1574
9 
91 
 
Inhalant allergy                       
 
Yes
No
77
1650
4 
96 
 
Eczema                                   
 
Yes
No
106
1621
6 
94 
 
Allergy*                                  
 
Yes
No
160
1567
9 
91 
 
Atopic disorder (any)                
 
Yes
No
246
1481
14 
86 
 
 Mean (sd) 
Age (years) at check-up 1727 5.9 (0.6) 
 
*inhalant allergy and/or eczema 
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higher risk of asthma in children delivered after induced labour, although this was 
not significant in the adjusted model (p=0.07).  
 
Discussion 
The present study showed that gestational age is inversely related to the risk of 
asthma and that a high ratio of neonatal head circumference to birth weight is a 
risk factor for atopic disorders, especially asthma. Both vacuum extraction and 
induced labour appeared to be related to a higher risk of allergic disease.  
Perinatal data 
Gestational age was in the present study shown to be related to a higher risk of 
asthma at six years. This is a confirmation of earlier findings (4, 6). One study 
relating gestational age to asthma in adulthood reported a similar result (11), but 
two other studies did not find this relation (10, 16). Kuehr et al reported an 
increased sensitization to aeroallergens in children born with a low gestational 
age (2). High gestational age was found to be associated with the risk of atopic 
dermatitis (9) and atopy (16), low gestational age was reported to be protective 
for rhinitis (11). Even though the observed relationships were not significant, our 
data tend to support these findings. A lack of association was reported earlier: 
between gestational age and the risk of sensitization to aeroallergens (7) and the 
risk of any atopy (8).  
Low birth weight has been shown to be associated with a higher risk of 
asthma (1,3,4,6,20,21), whereas high birth weight has been shown to be 
positively related to total IgE (5), the risk of atopic dermatitis (9) and the risk of 
asthma (12,21). The result of the present study, showing an inverse relationship 
between birth weight and the risk of asthma, although not statistically significant, 
is in concordance with the literature. Although a higher risk of asthma or a higher 
risk of atopic dermatitis in children with high birth weight could not be confirmed 
in this study, we observed a lower risk of eczema in low birth weight children. 
This was also reported by Siltanen et al (17). An explanation for the higher risk of 
asthma in prematurely born children and low birth weight children might be that 
these conditions are characterized by disturbed lung growth and result in reduced 
lung function. Small airway size gives rise to wheezing symptoms during viral 
infections, especially in the first year of life, and this is often labelled as asthma 
(36). The inconsistency of study results concerning the relationship between birth 
weight and asthma might be explained by the different phenotypes of asthma: a 
higher risk of non-atopic asthma in low birth weight groups and, seeing the 
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positive relationship between birth weight and IgE, a higher risk of atopic asthma 
in high birth weight groups could be conceivable. 
Neonatal head circumference was not found to be related to any of the 
outcome variables in the present study. Several studies have reported positive 
relationships between neonatal head circumference and the risk of asthma or 
increased total IgE (5,8,12,13,14), although the findings are not unequivocal. 
Some studies reported the lack of a relationship with asthma (10,12,13) or atopic 
disorders (8,12,13). The positive relationship between neonatal head 
circumference and total IgE concentration has raised the hypothesis, put forward 
by Godfrey et al (5), that a sustaining brain growth at the expense of the trunk, 
in particular the thymus, promotes the development of atopic disease. However, 
this hypothesis has been falsified by Benn et al (18) who found a positive 
relationship between neonatal head circumference and thymus size in the first 
week of life. He also showed that neonatal thymus size is not associated with 
allergic disease at the age of five years. Katz et al (24) examined the relationship 
between hayfever and the ratio of neonatal head circumference to birth weight, a 
measurement which better reflects the relative growth of the brain than absolute 
neonatal head circumference. They found that children with a high ratio had a 
lower risk of hay fever. Our own results suggest an increased risk of atopy in 
newborns with a relatively large ratio of neonatal head circumference to birth 
weight and hence support the hypothesis put forward by Godfrey et al (5)  . 
Obstetrical complications  
Children delivered by caesarean section have a higher risk of asthma (15, 19, 23, 
26), and allergy (18, 23). Other obstetric complications are also reported to be 
associated with a higher risk of asthma (15, 20). Although, in line with other 
studies (15, 19, 23, 26), we found a 50% higher prevalence of asthma in children 
delivered by caesarean section, the relationship disappeared after adjustment for 
confounding factors. One of these confounding factors was the ratio of neonatal 
head circumference to birth weight in the multivariate model. However, neither 
this measure nor neonatal head circumference alone was considered as a 
confounder in the four studies mentioned. We therefore suggest that the excess 
risk found in other studies may be due to residual confounding.  
Like Xu et al (19) we did not observe a relationship between caesarean 
section and allergy. Unlike them (15), however, we did not find an excess risk of 
asthma in children delivered with vacuum extraction, although we did find an 
increased risk of allergy in such children. Children delivered after induced labour 
had a higher risk of inhalant allergy and (to a lesser extent) asthma; Annesi-
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Maesano et al (20) also found a weak relationship with asthma. The mechanisms 
underlying the relationships between obstetric complications and atopic disorders 
are unclear. It has been suggested that incubator care, being more probable after 
a delivery with complications, might delay the contact of the newborn with 
microbes and thus affect the Th2Æ Th1 shift (15).  
Limitations of this study 
As stated before (28) the data used in this study were obtained from routinely 
collected records and we cannot exclude inaccuracy of data, including under- or 
overreporting of the diseases under study. Therefore it is possible that some of 
the relationships found in this study are due to residual confounding.  
 Selection bias cannot be excluded, because, due to the study design, 
families with only one child were not included. Consequently possibly atopic 
children with perinatal problems are underrepresented in this study. This may 
have attenuated the resulting relationships.  
Neonatal head circumference was often not recorded, because this 
measurement is generally not performed in home deliveries. Firstly this affected 
the power of the statistical tests. Secondly, while analyses with this variable were 
probably restricted to a selected population (i.e. hospital deliveries), this could 
have yielded spurious results. However, missing data on neonatal head 
circumference  was not related to any of the outcome measures, and hence 
selection bias can be excluded. Provided a report of the delivery was available, 
the other perinatal variables were complete. The lack of a delivery report is 
unlikely to be related to the health status of the newborn or the child at the age 
of six years: files with missing delivery reports were either very old or contained 
data of children born in a different region or country.  
No data were available on smoking by the mother during pregnancy. 
Intrauterine exposure to tobacco components is related to both birth weight and 
childhood respiratory symptoms (37) and should therefore be considered as an 
important confounder in the relationship between asthma and birth weight. 
Therefore the weak relationship observed between birth weight and asthma could 
be due to residual confounding. However, other studies which did adjust for 
smoking during pregnancy reported the same relationship. 
Because no distinction could be made between the different phenotypes of 
asthma at the age of six years and observations at earlier ages were lacking, we 
could not examine associations pertaining to a specific phenotype. 
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Conclusion 
Prematurity is a risk factor for asthma at six years, and special procedures during 
delivery, such as vacuum extraction and induced labour, are associated with a 
higher risk of atopic disorders. We also demonstrated that a high ratio of 
neonatal head circumference to birth weight is related to a higher risk of atopic 
disorders. Although some of these results confirm earlier findings, all results 
should be viewed with the possibility of residual confounding. Therefore further 
research into these relationships and their underlying mechanisms is needed. A 
better understanding could contribute to the prevention of atopic diseases.  
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Vaccinations 
DTPPo 
In chapter 2 we concluded that, at primary school age, DTPPo vaccinated children 
were not more often atopic than unvaccinated children. As this study was 
conducted in a religious group in The Netherlands, where part of the population 
refuses vaccinations for religious reasons, the problem of confounding by 
indication, which may have biased other studies, was no reason for concern 
(1,2). Moreover, the majority of the group that was not vaccinated for DTPPo did 
not receive other childhood vaccinations either, so our findings also appear to 
exonerate additives used in these vaccines, such as aluminium containing 
adjuvants. This conclusion is very reassuring for parents who fear possible long 
term adverse effects of vaccinations for their children and, if communicated well, 
our finding may help reverse the declining vaccination coverage. 
 In an unvaccinated subgroup of study population II (chapter 3) and a 
subgroup of study population I (chapter 2) we even found that at primary school 
age vaccinated children were less atopic than their unvaccinated counterparts. 
Although the basis of this conclusion is not very robust because of the small 
numbers in these subgroups, similar results were obtained in the MAS-cohort (3) 
and in a worldwide ecological study (4). This result would fit well in the hygiene 
hypothesis as vaccinations expose children at a very young age to (attenuated) 
pathogens, thus stimulating their immune system to the development of IL-10 
producing T-regulatory cells. If this is a “true” difference between vaccinated and 
unvaccinated children, we may speculate that the reason why we did not find this 
effect in the reported symptoms in chapter 2 is that reports obtained from 
parents may be biased towards a “desirable” study conclusion. It may be 
worthwhile to conduct another study with objective measurements of asthma and 
atopy as primary outcome.  
Hib 
In chapter 4 we concluded that there was no additional risk of atopy due to the 
Hib vaccination in primary school children who were DTPPo vaccinated. As these 
findings  agree with those from the (few) other available studies (3-7), we are 
clearly justified to conclude that Hib vaccination carries no additional risk of atopy 
in childhood .  
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Birth order and sibship size 
In previous studies the “sibling effect” was explored by relating atopy to the 
number of older siblings, birth order, family size, the number of younger siblings 
and sibship size (8). As several of these variables are linearly dependent on each 
other, as explained in chapter I (General Introduction), it sufficed to study the 
role of birth order and sibship size as risk factors for atopic disease. Identifying 
which of the two drives the development of atopy could be an essential step in 
unraveling the pathogenesis of atopy. However, it is difficult to disentangle the 
effects of these two factors (9). In a random sample of individuals sibship size 
and birth order are strongly correlated, and including them both into a regression 
model would not yield a definite answer, unless both effects are assessed within 
families. We demonstrated in a within-family study, that birth order, and not 
family size, was a risk factor for inhalant allergy. This confirms Strachan’s 
conclusion that older siblings have a stronger impact on allergy than younger 
siblings (10).  
Timing of birth order effect 
Knowledge of the age the birth order effect develops would also help to 
understand its underlying mechanisms. A negative relationship between maternal 
atopy and parity was found by Sunyer et al (11). Murine experiments have 
demonstrated that the status of the placenta changes after multiple births (12), 
and IgE measurements in cord blood have shown that the birth order effect is 
already present at birth (13, 14). Surely, this prenatal birth order effect does not 
preclude a possible, additional effect of more exposure to pathogens from other 
siblings in the family. While this prenatal effect could be due to more exposure to 
pathogens of the mother during pregnancy if she already has more children, a 
more plausible explanation would be that the gene/maternal-fetal interaction 
changes with increasing parity (14). Genetic research and research on a 
molecular level has to reveal the exact mechanism. Recent research has indeed 
shown that the maternal-fetal interaction (and thus prenatal development) is 
influenced by parity and genetic make-up (15) and even by the gender of older 
siblings (16). During childbirth, fetal cells may enter the maternal circulation and 
during this process the mother’s immune system may develop tolerance to fetal 
antigens. During successive pregnancies the fetuses may take advantage of this 
tolerance, especially if they have the same biological father as the first child.  
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Genetic susceptibility 
Another aspect of the birth order effect, is its genetic susceptibiliy, i.e. are there 
genes, of the mother or the child, that are predictors of the birth order effect? In 
other words: do some people benefit from the birth order effect while others do 
not? Knowledge on this area would both provide insight into the underlying 
mechanism of the birth order effect and outline which groups of people would 
benefit from preventive actions. 
 
Perinatal data 
One of our findings in chapter 6 (study population 2) was, that children with a 
gestational age of less than 36 weeks had a higher risk of asthma at six years of 
age. This was a confirmation of findings in other studies. Preterm infants often 
have a surfactant deficiency in their lungs, leading to respiratory distress 
syndrome, lower lung function and a higher risk of wheezing (17).  
 Our finding that a high ratio of head circumference and birth weight was 
associated with a higher risk of atopic disorders needs confirmation in other 
studies. The association should not be seen as support for the hypothesis that an 
excessive fetal growth of the brain at the expense of the thymus (reflected by a 
high head circumference to birth weight ratio) leads to atopy at a later age (18), 
because no relationship between thymus size and atopy was found (19). The 
association rather appears to be based on a complicated interplay between 
genes, mother-fetal interaction and probably environment, as was suggested by 
the recent demonstration of a positive association between the INS VNTR III/III 
genotype and head circumference; a relationship that increased with parity (15). 
Also, head circumference and birth weight are both associated with birth order, 
first borns being lighter and having smaller heads than second and higher borns 
(20).  
 A positive relationship between caesarean section and atopy was not 
confirmed by our study. However, we found a higher risk of allergy in children 
delivered by vacuum extraction and after induced labour. The mechanism 
underlying these associations is unclear. It could be that incubator care is a 
causal factor, but  confounding factors in the intrauterine environment would 
seem more plausible.  
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Limitations of the studies 
The design of the study with study population I (answering the questions on 
vaccinations) was cross-sectional. The main disadvantage of this type of design is 
that several variables are assessed retrospectively. The risk factor under study, 
however, was validated in a random subgroup by comparing  reported data with 
officially registered data, a comparison that yielded an almost 100% agreement. 
Validation of reported data by means of determination of IgG antibodies in sera 
identified some misclassification, but this is unlikely to have influenced our 
conclusions. 
 The study with population II (answering the questions on sibling effect 
and perinatal factors) was a retrospective cohort study. The main disadvantage 
of this design is that data were collected during routine health check-ups which 
may have introduced some amount of misclassification (likely non-differential and 
thus effect diluting). Moreover, as some possibly important confounders, such as 
exposure to smoking, were not available, residual confounding is possible. 
However, probably most of these confounders were family characteristics and 
since comparisons were made within families, this omission is unlikely to be 
consequential. 
 
Recommendations for daily practice 
It is important to communicate the results of vaccination studies to the general 
public in order to allay the fear of long term side-effects. These results can help  
preventive health care workers to advise parents in the process of considering 
the pro’s and contra’s of childhood vaccinations. Therefore these results should 
not only be published in scientific journals, but also communicated in public 
newspapers and magazines. 
 
Recommendations for future research 
We recommend to monitor the development of atopy when new vaccinations are 
added to National Vaccination Programmes.   
We also recommend to study the mechanism underlying the in utero birth 
order effect. Epidemiological research, comparing sibships with one biological 
father with those with more biological fathers (not uncommon in Africa), could 
reveal whether mothers develop tolerance to fetal antigens after multiple births, 
an issue that may also be addressed by genotyping mother, child, and older 
siblings. If the hypothesis proves to be true, this could be a starting point for 
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preventive measures, for instance by artificially inducing tolerance to paternal 
tissues before preganacy. Genotyping research is also recommended to identify 
polymorphisms associated with susceptibility to the birth order effect.  
The mechanism(s) underlying the relationships of perinatal data and 
interventions during labour with atopy in childhood could be elucidated by 
prospective studies which measure IgE in cord blood to assess whether a higher 
risk of atopy in childhood was already present in utero. 
 
References 
1. Koppen S, De Groot R, Neijens HJ, Nagelkerke N, Van Eden W, Rumke HC. No 
epidemiological evidence for infant vaccinations to cause allergic disease.  
Vaccine 2004;22:3375-85.  
2. Bernsen RM, van der Wouden JC. Re: No epidemiological evidence for infant 
vaccinations to cause allergic disease. Letter to the Editor. Vaccine 
2005;23:1427. 
3. Gruber C, Illi S, Lau S, Nickel R, Forster J, Kamin W, Bauer CP, Wahn V, 
Wahn U; MAS-90 Study Group. Transient suppression of atopy in early 
childhood is associated with high vaccination coverage. Pediatrics 2003 
Mar;111:e282-8. 
4. Anderson HR, Poloniecki JD, Strachan DP, Beasley R, Bjorksten B, Asher MI; 
ISAAC Phase 1 Study Group. Immunization and symptoms of atopic disease 
in children: results from the International Study of Asthma and Allergies in 
Childhood. Am J Public Health 2001;91:1126-9. 
5. Mommers M, Weishoff-Houben M, Swaen GM, Creemers H, Freund H, Dott W, 
van Schayck CP. Infant immunization and the occurrence of atopic disease in 
Dutch and German children: a nested case-control study. Pediatr Pulmonol 
2004;38:329-34. 
6. Laubereau B, Grote V, Holscher G, Holscher B, Frye C, Wichmann HE, 
Heinrich J. Vaccination against Haemophilus influenzae type B and atopy in 
east German schoolchildren. Eur J Med Res 2002;7:387-92. 
7. DeStefano F, Gu D, Kramarz P, Truman BI, Iademarco MF, Mullooly JP, 
Jackson LA, Davis RL, Black SB, Shinefield HR, Marcy SM, Ward JI, Chen RT; 
Vaccine Safety Datalink Research Group. Childhood vaccinations and risk of 
asthma. Pediatr Infect Dis J 2002;21:498-504. 
8. Karmaus W, Botezan C. Does a higher number of siblings protect against the 
development of allergy and asthma? A review. J Epidemiol Community Health 
2002;56:209-17. 
 108
9. Ponsonby AL, Couper D, Dwyer T, Carmichael A. Cross-sectional study of the 
relation between sibling number and asthma, hay fever and eczema. Arch Dis 
Child  1998;79:328-33.  
10. Strachan DP. Hay fever, hygiene, and household size. Br Med J 
1989;299:1259-60. 
11. Sunyer J, Anto JM, Harris J, Torrent M, Vall O, Cullinan P, Newman-Taylor A; 
AMICS study. Asthma Multi-centre Infants Cohort Study. Maternal atopy and 
parity. Clin Exp Allergy 2001;31:1352-5. 
12. Lagadari M, Blois S, Margni R, Miranda S. Analysis of macrophage presence in 
murine placenta: influence of age and parity status. Am J Reprod Immunol 
2004;51:49-55. 
13. Karmaus W, Arshad H, Mattes J. Does the sibling effect have its origin in 
utero? Investigating birth order, cord blood immunoglobulin E concentration, 
and allergic sensitization at age 4 years. Am J Epidemiol 2001;154:909-15. 
14. Devereux G, Barker RN, Seaton A. Antenatal determinants of neonatal 
immune responses to allergens. Clin Exp Allergy 2002;32:43-50. 
15. Ong KK, Petry CJ, Barratt BJ, Ring S, Cordell HJ, Wingate DL, Pembrey ME, 
Todd JA, Dunger DB; Avon Longitudinal Study of Pregnancy and Childhood 
Study Team. Maternal-fetal interactions and birth order influence insulin 
variable number of tandem repeats allele class associations with head size at 
birth and childhood weight gain. Diabetes 2004;53:1128-33. 
16. Cote K, Blanchard R, Lalumiere ML. The influence of birth order on birth 
weight: does the sex of preceding siblings matter? J Biosoc Sci 2003;35:455-
62. 
17. Speer CP, Silverman M. Issues relating to children born prematurely. Eur 
Respir J 1998;27 (Suppl):13s-16s. 
18. Godfrey KM, Barker DJ, Osmond C. Disproportionate fetal growth and raised 
IgE concentration in adult life. Clin Exp Allergy 1994;24:641-8. 
19. Benn CS, Jeppesen DL, Hasselbalch H, Olesen AB, Nielsen J, Bjorksten B, 
Lisse I, Aaby P. Thymus size and head circumference at birth and the 
development of allergic diseases. Clin Exp Allergy 2001;31:1862-6. 
20. Ong KK, Preece MA, Emmett PM, Ahmed ML, Dunger DB; ALSPAC Study 
Team. Size at birth and early childhood growth in relation to maternal 
smoking, parity and infant breast-feeding: longitudinal birth cohort study and 
analysis. Pediatric Research 2002;52:863-867. 
  
 8 
Summary & samenvatting 
 
 
 
 111
Summary 
 
Atopic disorders have become increasingly prevalent in the western world during 
the last decades of the 20th century. Research concerning the cause(s) of this 
increase has so far suggested a complex interplay between genetic and 
environmental factors. These studies have also indicated that priming starts at a 
very young age, even before birth. Therefore most studies on this subject have 
been in children. No clear causes of the increase of these disorders have come up 
so far, although there are indications that the increased hygienic living-conditions 
could play a role. Knowledge of causal factors would open opportunities for 
prevention. The aim of this thesis was to contribute a small piece to the immense 
endeavour of building foundations for prevention strategies. It also aimed at 
yielding objective information on implications of childhood vaccinations as a tool 
for workers in the field of preventive health care and for the general public.  
 The study population described in the chapters 2 and 4 were 8-12 year old 
children of the Orthodox Reformed (Protestant) population, living in an area in 
the Netherlands which stretches from the south-west to the east (study 
population I). Chapters 3, 5 and 6 apply to retrospectively collected health report 
data of a cohort of 700 families with index children born in 1988-1990 (study 
population II). These files contained reports of health check-ups of children living 
in Zwijndrecht, a town south of Rotterdam, at the age of 6 years.  
Chapter 1 gives an introduction and discusses the background of the thesis: the 
prevalence of atopic disorders has increased dramatically in the western world 
over the last decades of the past century and much effort has been put into 
finding the cause(s) of this increase. The hygiene hypothesis assumes that this 
increase is caused by a too hygienic environment where children are not enough 
exposed to pathogens. This exposure is said to be necessary for a healthy 
development of their immune system. Extensive research has been conducted to 
test the hygiene hypothesis, and, although much of the evidence is conflicting, 
there is some evidence that some aspects of hygiene are related to the 
development of atopic disorders. In this thesis we focused on two aspects of 
“hygiene”: vaccinations and family size.  
Chapter 2 presents a study of the relationship between the diphtheria-tetanus-
pertussis-poliomyelitis vaccination (DTPPo) in the first year of life and reported 
atopic disorders at age 8-12 years. We conducted this study in children of 
Orthodox Reformed (Protestant) families in the Netherlands (study population I). 
A part of these families refuse vaccinations for religious reasons, and therefore 
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we could compare vaccinated and unvaccinated children in a rather homogenous 
population. We included children via Orthodox Reformed schools, sent in total 
almost 4500 questionnaires of which 1875 (42%) were returned. The conclusion 
of this study is, that vaccinated and unvaccinated children have an equal risk of 
atopy.  
In Chapter 3 we addressed the same research question as in chapter 2. 
However, this study was conducted in children of 700 families with index children 
born in 1988-1990 (study population II) and the outcome of interest was atopy 
at age 6 years. Data were collected from reports of routinely conducted health 
examinations at the age of 6 years. Although we focussed on the pertussis 
vaccination at first, it became evident that there was almost 100% overlap with 
the DTPPo vaccination. The conclusion of this study is, that unvaccinated children 
had a higher risk of atopy at age 6 years. However, the number of unvaccinated 
children in this study was small and therefore the result is not reliable on its own. 
Chapter 4 describes a study on the relationship between the Haemophilus 
influenzae type b vaccination (Hib) and reported atopic disorders at age 8-12 
years. This study was conducted in the DTPPo vaccinated part of study population 
I. The Hib vaccination was introduced in the Netherlands in 1993, implying that a 
part of these DTPPo vaccinated children did not regularly get the Hib vaccination 
in the first year of life. This study concluded that there was no indication for a 
different risk of atopy due to the Hib vaccination. 
In Chapter 5 we investigated the so-called “sibling effect” (the phenomenon first 
described in 1986 that children from larger families have a smaller risk of atopic 
disorders than children from small families). This study was conducted in study 
population II. Because we studied the sibling effect within families, we were able 
to disentangle the independent effects of sibship size and birth order. In an 
ordinary cohort of children these variables are usually strongly correlated and it is 
consequently not possible to disentangle their effects From this study it became 
evident, that a higher birth order (or a higher number of older siblings) is 
associated with a lower risk of allergy, independent of the size of the sibship. 
In chapter 6 we studied the associations of atopy at age 6 years with perinatal 
characteristics (gestational age, birth weight and neonatal head circumference) 
and obstetric complications. These associations were studied in population II.  
We concluded, confirming earlier findings, that premature children have a higher 
risk of asthma at age 6 years. Other findings were that children with a high ratio 
of head circumference to birth weight, children delivered with vacuum extraction, 
and children delivered after induced labour had a higher risk of allergy. 
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Chapter 7 discusses the findings in this thesis, also in relation to what was 
already known on the etiology of atopic disorders.  
The finding that the DTPPo vaccination and the Hib vaccination are not 
related to atopic disorders is reassuring for those parents who are hesitating 
about the health effects of vaccinations and could, if communicated well, 
contribute to stop the, in some countries (like the UK and the Netherlands), 
steady decrease of the vaccination coverage.  
The findings on birth order and perinatal risk factors are mere links in a 
chain of hypotheses on the mechanisms underlying atopic disorders and could 
thus contribute to preventive strategies in the future.  
We finally speculate on possible mechanisms on the basis of our findings 
and results of studies conducted on other topics and make recommendations for 
daily practice and future research. 
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Samenvatting 
 
Atopische aandoeningen komen steeds vaker voor. Deze stijging heeft in de  
laatste decennia van de vorige eeuw plaatsgevonden. Onderzoek naar de 
oorzaken van deze stijging heeft een ingewikkeld samenspel tussen aanleg en 
omgevingsfactoren laten zien. Uit dit onderzoek is ook gebleken, dat de 
aandoening al op heel vroege leeftijd begint, zelfs al voor de geboorte. Daarom 
wordt er veel onderzoek in kinderen gedaan. Tot nu toe heeft men niet echt 
duidelijke oorzaken voor het meer vóórkomen kunnen vinden. Er zijn wel 
aanwijzingen dat misschien de toegenomen hygiëne een rol speelt. Als we precies 
zouden weten wat de oorzaken zijn, zouden we een preventieprogramma kunnen 
opzetten. Het doel van deze studies was een klein stukje bij te dragen aan de 
grote klus om een goede fundering voor zo’n preventieprogramma te leggen. Een 
ander doel was objectieve informatie te vergaren over de impact van 
kindervaccinaties op het krijgen van atopie. Deze informatie is bedoeld voor 
mensen die werken in de preventieve gezondheidszorg en voor de hele 
bevolking. 
 De studiepopulatie die wordt beschreven in hoofdstuk 2 en 4 (studie-
populatie I) waren 8-12 jaar oude kinderen uit de Reformatorische groep die 
woont in een strook die zich uitstrekt van het zuid-westen naar het oosten an 
Nederland (ook wel de “Bible Belt” genoemd). Hoofdstuk 3, 5 en 6 hebben 
betrekking op gegevens uit rapporten van schoolartsbezoeken van een cohort 
van 700 gezinnen met index-kinderen, die tussen begin 1988 en eind 1990 zijn 
geboren (studie-populatie II). Deze kinderen woonden ten tijde van hun bezoek 
aan de schoolarts (op 6-jarige leeftijd) in Zwijndrecht. 
Hoofdstuk 1 is een inleiding en bespreekt de achtergronden van de studies in dit 
proefschrift: atopische aandoeningen komen steeds vaker voor in de westerse 
wereld. De echte toename heeft gedurende de laatste decennia van de vorige 
eeuw plaatsgevonden. Er is veel onderzoek gedaan naar de oorzaken van deze 
toename. Volgens de hygiënehypothese is de oorzaak een te hygiënische 
leefomgeving, waarin kinderen niet genoeg aan ziekteverwekkers worden 
blootgesteld. Men neemt aan, dat deze blootstelling nodig is voor een gezonde 
ontwikkeling van het immuunsysteem. Er zijn veel studies gedaan met als doel 
de hygiënehypothese te testen. Hoewel veel resultaten elkaar tegenspreken, lijkt 
het er toch op, dat sommige aspecten van hygiëne gerelateerd zijn aan het risico 
op atopische aandoeningen. In dit proefschrift worden twee aspecten van hygiëne 
bestudeerd: vaccinaties en gezinsgrootte. 
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Hoofdstuk 2 beschrijft een studie naar de relatie tussen de difterie-tetanus-
kinkhoest-polio vaccinatie (DKTP) in het eerste levensjaar en gerapporteerde 
atopische aandoeningen op de leeftijd van 8-12 jaar. Deze studie werd 
uitgevoerd in een groep reformatorische kinderen in Nederland (studiepopulatie 
I). Een deel van de ouders van deze kinderen wijst vaccinaties af uit 
godsdienstige overwegingen. Daarom was het mogelijk binnen een redelijk 
homogene groep gavccineerde en ongevaccineerde kinderen met elkaar te 
vergelijken. We includeerden kinderen via reformatorische scholen en verzonden 
bijna 4500 vragenlijsten, waarvan er 1875 (42%) ingevuld werden 
teruggestuurd.  De conclusie van deze studie is, dat gevaccineerde en 
ongevaccineerde kinderen een even grote kans hebben op een atopische 
aandoening.  
In hoofdstuk 3 onderzochten wij dezelfde relatie als in hoofdstuk 2, maar nu in 
de kinderen van 700 gezinnen in Zwijndrecht met index-kinderen geboren in 
1988-1990 (studie-populatie II). In deze studie werd gekeken naar atopische 
aandoeningen op de leeftijd van 6 jaar. Data werd verzameld uit verslagen van 
schoolartsonderzoeken op de leeftijd van 6 jaar. Onze hypothese betrof eigenlijk 
de kinkhoest vaccinatie, maar het bleek dat als een kind niet gevaccineerd was 
tegen kinkhoest, hij/zij bijna altijd ook niet gevaccineerd was met de DKTP-
cocktail. De conclusie van deze studie is, dat ongevaccineerde kinderen een 
grotere kans hebben op een atopische aandoening op de leeftijd van 6 jaar. 
Echter, het aantal ongevaccineerde kinderen in deze studie was klein en daarom 
is dit resultaat alleen niet echt een sterk bewijs. 
In hoofdstuk 4 beschrijven wij een studie naar de relatie tussen de Haemophilus 
influenzae type b vaccinatie (Hib) en gerapporteerde atopische aandoeningen op 
de leeftijd van 8-12 jaar. De onderzoeksvraag werd onderzocht in het DKTP 
gevaccineerde deel van studiepopulatie I. De Hib vaccinatie werd in Nederland in 
1993 aan het Rijks Vaccinatie Programma toegevoegd. Studiepopulatie I werd 
deels vóór, deels na 1993 geboren. Daardoor heeft een deel van deze DKTP 
gevaccineerde kinderen de Hib in het eerste levensjaar niet ontvangen. De 
conclusie is, dat er geen aanwijzing is voor een veranderd risico op atopische 
aandoeningen ten gevolge van de Hib vaccinatie. 
In hoofdstuk 5 onderzochten wij het zogenoemde “sibling effect”. Deze term 
staat voor het verschijnsel (voor het eerst beschreven in 1986), dat kinderen met 
veel broers en zussen minder kans op een atopische aandoening hebben dan 
kinderen met minder broers en zussen. We voerden deze studie uit in 
studiepopulatie II. Omdat de onderzoekseenheden in deze studiepopulatie 
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gezinnen zijn, waren we in staat de variabele “gezinsgrootte” te onderscheiden 
van de variabele “plaats in de kinderrij”. In een “gewoon” cohort van kinderen 
zijn deze twee variabelen n.l. sterk gecorreleerd, en zijn de effecten niet goed te 
onderscheiden. Uit deze studie bleek, dat hoe hoger de plaats in de kinderrij 
binnen een gezin (of: hoe meer oudere broers en zussen) des te kleiner de kans 
op een atopische aandoening, onafhankelijk van de gezinsgrootte. 
Hoofdstuk 6 beschrijft de relaties van atopische aandoeningen op de leeftijd van 
6 jaar met geboortegegevens (zwangerschapsduur, geboortegewicht, 
schedelomtrek en complicaties bij de geboorte, zoals een keizersnede, 
vacuumverlossing, tangverlossing of een ingeleide bevalling). Deze studie werd 
gedaan in studiepopulatie II. We vonden, dat te vroeg geboren kinderen een 
grotere kans hebben op astma op zesjarige leeftijd dan kinderen die à terme 
geboren zijn. Een andere bevinding was, dat kinderen met een relatief grote 
schedelomtrek (ten opzichte van hun gewicht), kinderen die met vacuum 
extractie waren geboren en kinderen bij wie de weeën waren opgewekt een 
grotere kans hadden om allergisch te zijn op zesjarige leeftijd. 
Hoofdstuk 7 bespreekt de bevindingen van dit proefschrift, ook in het licht van 
wat al bekend was over de etiologie van atopische aandoeningen.  
De conclusie dat vaccineren niet uitmaakt voor het krijgen van atopische 
aandoeningen is geruststellend voor ouders die twijfels hebben over de effecten 
van vaccinaties op de gezondheid van hun kinderen. Als dit resultaat bredere 
bekendheid krijgt, kan het ertoe bijdragen dat de (in sommige landen zoals 
Engeland en Nederland) dalende vaccinatiegraad wordt omgebogen. 
De resultaten over plaats in de kinderrij en perinatale risicofactoren zijn bijdragen 
aan de vorming van hypothesen over de mechanismen in het ontstaan van 
atopische aandoeningen. Zij kunnen aldus bijdragen aan de ontwikkeling van 
toekomstige preventieprogramma’s.  
Verder speculeren we op grond van onze bevindingen en andere 
onderzoeksresultaten over mogelijke mechanismen en we doen aanbevelingen 
voor de dagelijkse praktijk en toekomstig onderzoek. 
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